{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:01:20Z","timestamp":1793638880612,"version":"4.5.1"},"reference-count":278,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,4,2]],"date-time":"2016-04-02T00:00:00Z","timestamp":1459555200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Foundation of Natural Science of China","doi-asserted-by":"crossref","award":["31471114"],"award-info":[{"award-number":["31471114"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Foundation of Natural Science of China","doi-asserted-by":"crossref","award":["81430024, 31271131"],"award-info":[{"award-number":["81430024, 31271131"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s12035-016-9879-1","type":"journal-article","created":{"date-parts":[[2016,4,2]],"date-time":"2016-04-02T05:49:16Z","timestamp":1459576156000},"page":"3078-3101","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":174,"title":["Brain Iron Metabolism Dysfunction in Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"54","author":[{"given":"Hong","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junxia","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,2]]},"reference":[{"issue":"5","key":"9879_CR1","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s00415-006-0369-7","volume":"254","author":"KJ Schweitzer","year":"2007","unstructured":"Schweitzer KJ, Brussel T, Leitner P, Kruger R, Bauer P, Woitalla D, Tomiuk J, Gasser T, Berg D (2007) Transcranial ultrasound in different monogenetic subtypes of Parkinson\u2019s disease. J Neurol 254(5):613\u2013616. doi: 10.1007\/s00415-006-0369-7","journal-title":"J Neurol"},{"issue":"10","key":"9879_CR2","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1007\/s00415-007-0567-y","volume":"254","author":"JM Hagenah","year":"2007","unstructured":"Hagenah JM, Konig IR, Becker B, Hilker R, Kasten M, Hedrich K, Pramstaller PP, Klein C, Seidel G (2007) Substantia nigra hyperechogenicity correlates with clinical status and number of Parkin mutated alleles. J Neurol 254(10):1407\u20131413. doi: 10.1007\/s00415-007-0567-y","journal-title":"J Neurol"},{"issue":"9","key":"9879_CR3","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1136\/jnnp.2007.142174","volume":"79","author":"JM Hagenah","year":"2008","unstructured":"Hagenah JM, Becker B, Bruggemann N, Djarmati A, Lohmann K, Sprenger A, Klein C, Seidel G (2008) Transcranial sonography findings in a large family with homozygous and heterozygous PINK1 mutations. J Neurol Neurosurg Psychiatry 79(9):1071\u20131074. doi: 10.1136\/jnnp.2007.142174","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"9879_CR4","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/mds.23644","volume":"26","author":"N Bruggemann","year":"2011","unstructured":"Bruggemann N, Hagenah J, Stanley K, Klein C, Wang C, Raymond D, Ozelius L, Bressman S, Saunders-Pullman R (2011) Substantia nigra hyperechogenicity with LRRK2 G2019S mutations. Mov Disord 26(5):885\u2013888. doi: 10.1002\/mds.23644","journal-title":"Mov Disord"},{"issue":"1","key":"9879_CR5","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/j.1471-4159.2010.06914.x","volume":"115","author":"W Xie","year":"2010","unstructured":"Xie W, Li X, Li C, Zhu W, Jankovic J, Le W (2010) Proteasome inhibition modeling nigral neuron degeneration in Parkinson\u2019s disease. J Neurochem 115(1):188\u2013199. doi: 10.1111\/j.1471-4159.2010.06914.x","journal-title":"J Neurochem"},{"issue":"6","key":"9879_CR6","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1111\/j.1471-4159.1989.tb07264.x","volume":"52","author":"DT Dexter","year":"1989","unstructured":"Dexter DT, Wells FR, Lees AJ, Agid F, Agid Y, Jenner P, Marsden CD (1989) Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson\u2019s disease. J Neurochem 52(6):1830\u20131836","journal-title":"J Neurochem"},{"issue":"8","key":"9879_CR7","doi-asserted-by":"publisher","first-page":"4055","DOI":"10.1210\/en.2010-0252","volume":"151","author":"TW Bastian","year":"2010","unstructured":"Bastian TW, Prohaska JR, Georgieff MK, Anderson GW (2010) Perinatal iron and copper deficiencies alter neonatal rat circulating and brain thyroid hormone concentrations. Endocrinology 151(8):4055\u20134065. doi: 10.1210\/en.2010-0252","journal-title":"Endocrinology"},{"issue":"4","key":"9879_CR8","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1474-4422(03)00353-3","volume":"2","author":"Y Ke","year":"2003","unstructured":"Ke Y, Ming Qian Z (2003) Iron misregulation in the brain: a primary cause of neurodegenerative disorders. Lancet Neurol 2(4):246\u2013253","journal-title":"Lancet Neurol"},{"issue":"3","key":"9879_CR9","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.arr.2004.01.003","volume":"3","author":"D Kaur","year":"2004","unstructured":"Kaur D, Andersen J (2004) Does cellular iron dysregulation play a causative role in Parkinson\u2019s disease? Ageing Res Rev 3(3):327\u2013343. doi: 10.1016\/j.arr.2004.01.003","journal-title":"Ageing Res Rev"},{"issue":"21","key":"9879_CR10","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1212\/01.wnl.0000262033.01945.9a","volume":"68","author":"AE Oakley","year":"2007","unstructured":"Oakley AE, Collingwood JF, Dobson J, Love G, Perrott HR, Edwardson JA, Elstner M, Morris CM (2007) Individual dopaminergic neurons show raised iron levels in Parkinson disease. Neurology 68(21):1820\u20131825. doi: 10.1212\/01.wnl.0000262033.01945.9a","journal-title":"Neurology"},{"key":"9879_CR11","doi-asserted-by":"publisher","unstructured":"Jiang H, Song N, Xu H, Zhang S, Wang J, Xie J (2010) Up-regulation of divalent metal transporter 1 in 6-hydroxydopamine intoxication is IRE\/IRP dependent. Cell Res. doi: 10.1038\/cr.2010.20","DOI":"10.1038\/cr.2010.20"},{"issue":"10","key":"9879_CR12","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/S1474-4422(14)70117-6","volume":"13","author":"RJ Ward","year":"2014","unstructured":"Ward RJ, Zucca FA, Duyn JH, Crichton RR, Zecca L (2014) The role of iron in brain ageing and neurodegenerative disorders. Lancet Neurol 13(10):1045\u20131060. doi: 10.1016\/S1474-4422(14)70117-6","journal-title":"Lancet Neurol"},{"key":"9879_CR13","doi-asserted-by":"publisher","first-page":"581256","DOI":"10.1155\/2014\/581256","volume":"2014","author":"S Ayton","year":"2014","unstructured":"Ayton S, Lei P (2014) Nigral iron elevation is an invariable feature of Parkinson\u2019s disease and is a sufficient cause of neurodegeneration. Biomed Res Int 2014:581256. doi: 10.1155\/2014\/581256","journal-title":"Biomed Res Int"},{"issue":"5","key":"9879_CR14","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/jnr.20113","volume":"76","author":"M Knutson","year":"2004","unstructured":"Knutson M, Menzies S, Connor J, Wessling-Resnick M (2004) Developmental, regional, and cellular expression of SFT\/UbcH5A and DMT1 mRNA in brain. J Neurosci Res 76(5):633\u2013641. doi: 10.1002\/jnr.20113","journal-title":"J Neurosci Res"},{"issue":"4","key":"9879_CR15","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s10534-012-9538-6","volume":"25","author":"RC McCarthy","year":"2012","unstructured":"McCarthy RC, Kosman DJ (2012) Mechanistic analysis of iron accumulation by endothelial cells of the BBB. Biometals 25(4):665\u2013675. doi: 10.1007\/s10534-012-9538-6","journal-title":"Biometals"},{"key":"9879_CR16","doi-asserted-by":"publisher","unstructured":"Rouault TA, Zhang DL, Jeong SY (2009) Brain iron homeostasis, the choroid plexus, and localization of iron transport proteins. Metab Brain Dis. doi: 10.1007\/s11011-009-9169-y","DOI":"10.1007\/s11011-009-9169-y"},{"issue":"1","key":"9879_CR17","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1148\/radiol.2522081399","volume":"252","author":"D Aquino","year":"2009","unstructured":"Aquino D, Bizzi A, Grisoli M, Garavaglia B, Bruzzone MG, Nardocci N, Savoiardo M, Chiapparini L (2009) Age-related iron deposition in the basal ganglia: quantitative analysis in healthy subjects. Radiology 252(1):165\u2013172. doi: 10.1148\/radiol.2522081399","journal-title":"Radiology"},{"issue":"2","key":"9879_CR18","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.neuroimage.2009.05.006","volume":"47","author":"A Pfefferbaum","year":"2009","unstructured":"Pfefferbaum A, Adalsteinsson E, Rohlfing T, Sullivan EV (2009) MRI estimates of brain iron concentration in normal aging: comparison of field-dependent (FDRI) and phase (SWI) methods. Neuroimage 47(2):493\u2013500. doi: 10.1016\/j.neuroimage.2009.05.006","journal-title":"Neuroimage"},{"issue":"26","key":"9879_CR19","doi-asserted-by":"publisher","first-page":"9843","DOI":"10.1073\/pnas.0403495101","volume":"101","author":"L Zecca","year":"2004","unstructured":"Zecca L, Stroppolo A, Gatti A, Tampellini D, Toscani M, Gallorini M, Giaveri G, Arosio P, Santambrogio P, Fariello RG, Karatekin E, Kleinman MH, Turro N, Hornykiewicz O, Zucca FA (2004) The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging. Proc Natl Acad Sci U S A 101(26):9843\u20139848. doi: 10.1073\/pnas.0403495101","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"9879_CR20","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s11689-010-9049-0","volume":"2","author":"ES Carlson","year":"2010","unstructured":"Carlson ES, Fretham SJ, Unger E, O\u2019Connor M, Petryk A, Schallert T, Rao R, Tkac I, Georgieff MK (2010) Hippocampus specific iron deficiency alters competition and cooperation between developing memory systems. J Neurodev Disord 2(3):133\u2013143. doi: 10.1007\/s11689-010-9049-0","journal-title":"J Neurodev Disord"},{"issue":"4","key":"9879_CR21","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3945\/jn.108.096354","volume":"139","author":"ES Carlson","year":"2009","unstructured":"Carlson ES, Tkac I, Magid R, O\u2019Connor MB, Andrews NC, Schallert T, Gunshin H, Georgieff MK, Petryk A (2009) Iron is essential for neuron development and memory function in mouse hippocampus. J Nutr 139(4):672\u2013679. doi: 10.3945\/jn.108.096354","journal-title":"J Nutr"},{"issue":"4","key":"9879_CR22","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/mnfr.200900158","volume":"54","author":"D Benton","year":"2010","unstructured":"Benton D (2010) The influence of dietary status on the cognitive performance of children. Mol Nutr Food Res 54(4):457\u2013470. doi: 10.1002\/mnfr.200900158","journal-title":"Mol Nutr Food Res"},{"issue":"2","key":"9879_CR23","doi-asserted-by":"publisher","first-page":"e358","DOI":"10.1542\/peds.2007-1332","volume":"121","author":"JG Millichap","year":"2008","unstructured":"Millichap JG (2008) Etiologic classification of attention-deficit\/hyperactivity disorder. Pediatrics 121(2):e358\u2013e365. doi: 10.1542\/peds.2007-1332","journal-title":"Pediatrics"},{"issue":"6","key":"9879_CR24","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nrneurol.2010.55","volume":"6","author":"C Trenkwalder","year":"2010","unstructured":"Trenkwalder C, Paulus W (2010) Restless legs syndrome: pathophysiology, clinical presentation and management. Nat Rev Neurol 6(6):337\u2013346. doi: 10.1038\/nrneurol.2010.55","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"9879_CR25","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1152\/physrev.2001.81.2.871","volume":"81","author":"N Baumann","year":"2001","unstructured":"Baumann N, Pham-Dinh D (2001) Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev 81(2):871\u2013927","journal-title":"Physiol Rev"},{"issue":"16","key":"9879_CR26","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1212\/WNL.0b013e3181a26b30","volume":"72","author":"EE Benarroch","year":"2009","unstructured":"Benarroch EE (2009) Brain iron homeostasis and neurodegenerative disease. Neurology 72(16):1436\u20131440. doi: 10.1212\/WNL.0b013e3181a26b30","journal-title":"Neurology"},{"issue":"1","key":"9879_CR27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1023\/A:1006948027674","volume":"20","author":"T Moos","year":"2000","unstructured":"Moos T, Morgan EH (2000) Transferrin and transferrin receptor function in brain barrier systems. Cell Mol Neurobiol 20(1):77\u201395","journal-title":"Cell Mol Neurobiol"},{"issue":"1","key":"9879_CR28","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.abb.2008.02.041","volume":"474","author":"A Waheed","year":"2008","unstructured":"Waheed A, Britton RS, Grubb JH, Sly WS, Fleming RE (2008) HFE association with transferrin receptor 2 increases cellular uptake of transferrin-bound iron. Arch Biochem Biophys 474(1):193\u2013197. doi: 10.1016\/j.abb.2008.02.041","journal-title":"Arch Biochem Biophys"},{"issue":"30","key":"9879_CR29","doi-asserted-by":"crossref","first-page":"20826","DOI":"10.1074\/jbc.274.30.20826","volume":"274","author":"H Kawabata","year":"1999","unstructured":"Kawabata H, Yang R, Hirama T, Vuong PT, Kawano S, Gombart AF, Koeffler HP (1999) Molecular cloning of transferrin receptor 2. A new member of the transferrin receptor-like family. J Biol Chem 274(30):20826\u201320832","journal-title":"J Biol Chem"},{"issue":"3","key":"9879_CR30","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S1357-2725(02)00258-3","volume":"35","author":"D Trinder","year":"2003","unstructured":"Trinder D, Baker E (2003) Transferrin receptor 2: a new molecule in iron metabolism. Int J Biochem Cell Biol 35(3):292\u2013296","journal-title":"Int J Biochem Cell Biol"},{"issue":"3","key":"9879_CR31","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.cmet.2009.02.004","volume":"9","author":"RE Fleming","year":"2009","unstructured":"Fleming RE (2009) Iron sensing as a partnership: HFE and transferrin receptor 2. Cell Metab 9(3):211\u2013212. doi: 10.1016\/j.cmet.2009.02.004","journal-title":"Cell Metab"},{"issue":"4","key":"9879_CR32","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.cmet.2008.03.008","volume":"7","author":"T Ganz","year":"2008","unstructured":"Ganz T (2008) Iron homeostasis: fitting the puzzle pieces together. Cell Metab 7(4):288\u2013290. doi: 10.1016\/j.cmet.2008.03.008","journal-title":"Cell Metab"},{"issue":"1","key":"9879_CR33","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/jcp.20095","volume":"202","author":"MG Kielmanowicz","year":"2005","unstructured":"Kielmanowicz MG, Laham N, Coligan JE, Lemonnier F, Ehrlich R (2005) Mouse HFE inhibits Tf-uptake and iron accumulation but induces non-transferrin bound iron (NTBI)-uptake in transformed mouse fibroblasts. J Cell Physiol 202(1):105\u2013114. doi: 10.1002\/jcp.20095","journal-title":"J Cell Physiol"},{"key":"9879_CR34","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1146\/annurev.pathol.4.110807.092205","volume":"4","author":"PL Lee","year":"2009","unstructured":"Lee PL, Beutler E (2009) Regulation of hepcidin and iron-overload disease. Annu Rev Pathol 4:489\u2013515. doi: 10.1146\/annurev.pathol.4.110807.092205","journal-title":"Annu Rev Pathol"},{"issue":"5","key":"9879_CR35","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1073\/pnas.042701499","volume":"99","author":"A Waheed","year":"2002","unstructured":"Waheed A, Grubb JH, Zhou XY, Tomatsu S, Fleming RE, Costaldi ME, Britton RS, Bacon BR, Sly WS (2002) Regulation of transferrin-mediated iron uptake by HFE, the protein defective in hereditary hemochromatosis. Proc Natl Acad Sci U S A 99(5):3117\u20133122. doi: 10.1073\/pnas.042701499","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"9879_CR36","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1139\/o06-059","volume":"84","author":"V Lopez","year":"2006","unstructured":"Lopez V, Suzuki YA, Lonnerdal B (2006) Ontogenic changes in lactoferrin receptor and DMT1 in mouse small intestine: implications for iron absorption during early life. Biochem Cell Biol 84(3):337\u2013344. doi: 10.1139\/o06-059","journal-title":"Biochem Cell Biol"},{"issue":"1","key":"9879_CR37","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1042\/BJ20061290","volume":"403","author":"B Mackenzie","year":"2007","unstructured":"Mackenzie B, Takanaga H, Hubert N, Rolfs A, Hediger MA (2007) Functional properties of multiple isoforms of human divalent metal-ion transporter 1 (DMT1). Biochem J 403(1):59\u201369. doi: 10.1042\/BJ20061290","journal-title":"Biochem J"},{"issue":"1","key":"9879_CR38","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.pediatrneurol.2007.08.014","volume":"38","author":"E Konofal","year":"2008","unstructured":"Konofal E, Lecendreux M, Deron J, Marchand M, Cortese S, Zaim M, Mouren MC, Arnulf I (2008) Effects of iron supplementation on attention deficit hyperactivity disorder in children. Pediatr Neurol 38(1):20\u201326. doi: 10.1016\/j.pediatrneurol.2007.08.014","journal-title":"Pediatr Neurol"},{"issue":"7-8","key":"9879_CR39","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.sleep.2007.04.022","volume":"8","author":"E Konofal","year":"2007","unstructured":"Konofal E, Cortese S, Marchand M, Mouren MC, Arnulf I, Lecendreux M (2007) Impact of restless legs syndrome and iron deficiency on attention-deficit\/hyperactivity disorder in children. Sleep Med 8(7-8):711\u2013715. doi: 10.1016\/j.sleep.2007.04.022","journal-title":"Sleep Med"},{"issue":"7","key":"9879_CR40","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1182\/blood-2005-10-4174","volume":"107","author":"EO Sekyere","year":"2006","unstructured":"Sekyere EO, Dunn LL, Rahmanto YS, Richardson DR (2006) Role of melanotransferrin in iron metabolism: studies using targeted gene disruption in vivo. Blood 107(7):2599\u20132601. doi: 10.1182\/blood-2005-10-4174","journal-title":"Blood"},{"issue":"4","key":"9879_CR41","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1111\/j.1471-4159.1991.tb11444.x","volume":"56","author":"D Ben-Shachar","year":"1991","unstructured":"Ben-Shachar D, Eshel G, Finberg JP, Youdim MB (1991) The iron chelator desferrioxamine (Desferal) retards 6-hydroxydopamine-induced degeneration of nigrostriatal dopamine neurons. J Neurochem 56(4):1441\u20131444","journal-title":"J Neurochem"},{"issue":"6","key":"9879_CR42","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S0891-5849(00)00169-6","volume":"28","author":"AM Lin","year":"2000","unstructured":"Lin AM, Ho LT (2000) Melatonin suppresses iron-induced neurodegeneration in rat brain. Free Radic Biol Med 28(6):904\u2013911","journal-title":"Free Radic Biol Med"},{"issue":"15","key":"9879_CR43","doi-asserted-by":"crossref","first-page":"6578","DOI":"10.1523\/JNEUROSCI.22-15-06578.2002","volume":"22","author":"BN Patel","year":"2002","unstructured":"Patel BN, Dunn RJ, Jeong SY, Zhu Q, Julien JP, David S (2002) Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury. J Neurosci 22(15):6578\u20136586, 20026652","journal-title":"J Neurosci"},{"issue":"6","key":"9879_CR44","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1002\/jnr.1256","volume":"66","author":"JR Burdo","year":"2001","unstructured":"Burdo JR, Menzies SL, Simpson IA, Garrick LM, Garrick MD, Dolan KG, Haile DJ, Beard JL, Connor JR (2001) Distribution of divalent metal transporter 1 and metal transport protein 1 in the normal and Belgrade rat. J Neurosci Res 66(6):1198\u20131207. doi: 10.1002\/jnr.1256","journal-title":"J Neurosci Res"},{"issue":"14","key":"9879_CR45","doi-asserted-by":"publisher","first-page":"3118","DOI":"10.1002\/jnr.21430","volume":"85","author":"N Song","year":"2007","unstructured":"Song N, Jiang H, Wang J, Xie JX (2007) Divalent metal transporter 1 up-regulation is involved in the 6-hydroxydopamine-induced ferrous iron influx. J Neurosci Res 85(14):3118\u20133126. doi: 10.1002\/jnr.21430","journal-title":"J Neurosci Res"},{"issue":"2","key":"9879_CR46","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1006\/bcmd.1998.0186","volume":"24","author":"PL Lee","year":"1998","unstructured":"Lee PL, Gelbart T, West C, Halloran C, Beutler E (1998) The human Nramp2 gene: characterization of the gene structure, alternative splicing, promoter region and polymorphisms. Blood Cells Mol Dis 24(2):199\u2013215. doi: 10.1006\/bcmd.1998.0186","journal-title":"Blood Cells Mol Dis"},{"issue":"19","key":"9879_CR47","doi-asserted-by":"publisher","first-page":"12345","DOI":"10.1073\/pnas.192423399","volume":"99","author":"N Hubert","year":"2002","unstructured":"Hubert N, Hentze MW (2002) Previously uncharacterized isoforms of divalent metal transporter (DMT)-1: implications for regulation and cellular function. Proc Natl Acad Sci U S A 99(19):12345\u201312350. doi: 10.1073\/pnas.192423399","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"36","key":"9879_CR48","doi-asserted-by":"publisher","first-page":"15489","DOI":"10.1073\/pnas.0904880106","volume":"106","author":"J Howitt","year":"2009","unstructured":"Howitt J, Putz U, Lackovic J, Doan A, Dorstyn L, Cheng H, Yang B, Chan-Ling T, Silke J, Kumar S, Tan SS (2009) Divalent metal transporter 1 (DMT1) regulation by Ndfip1 prevents metal toxicity in human neurons. Proc Natl Acad Sci U S A 106(36):15489\u201315494. doi: 10.1073\/pnas.0904880106","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9879_CR49","doi-asserted-by":"publisher","unstructured":"Roth JA, Singleton S, Feng J, Garrick M, Paradkar PN (2010) Parkin regulates metal transport via proteasomal degradation of the 1B isoforms of divalent metal transporter 1 (DMT1). J Neurochem. doi: 10.1111\/j.1471-4159.2010.06607.x","DOI":"10.1111\/j.1471-4159.2010.06607.x"},{"issue":"5","key":"9879_CR50","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.neurobiolaging.2004.06.002","volume":"26","author":"Y Ke","year":"2005","unstructured":"Ke Y, Chang YZ, Duan XL, Du JR, Zhu L, Wang K, Yang XD, Ho KP, Qian ZM (2005) Age-dependent and iron-independent expression of two mRNA isoforms of divalent metal transporter 1 in rat brain. Neurobiol Aging 26(5):739\u2013748. doi: 10.1016\/j.neurobiolaging.2004.06.002","journal-title":"Neurobiol Aging"},{"issue":"3","key":"9879_CR51","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/S0306-4522(99)00207-9","volume":"93","author":"JR Burdo","year":"1999","unstructured":"Burdo JR, Martin J, Menzies SL, Dolan KG, Romano MA, Fletcher RJ, Garrick MD, Garrick LM, Connor JR (1999) Cellular distribution of iron in the brain of the Belgrade rat. Neuroscience 93(3):1189\u20131196","journal-title":"Neuroscience"},{"issue":"2","key":"9879_CR52","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1046\/j.1471-4159.1999.720868.x","volume":"72","author":"SW Hulet","year":"1999","unstructured":"Hulet SW, Hess EJ, Debinski W, Arosio P, Bruce K, Powers S, Connor JR (1999) Characterization and distribution of ferritin binding sites in the adult mouse brain. J Neurochem 72(2):868\u2013874","journal-title":"J Neurochem"},{"issue":"7","key":"9879_CR53","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1084\/jem.20042433","volume":"202","author":"TT Chen","year":"2005","unstructured":"Chen TT, Li L, Chung DH, Allen CD, Torti SV, Torti FM, Cyster JG, Chen CY, Brodsky FM, Niemi EC, Nakamura MC, Seaman WE, Daws MR (2005) TIM-2 is expressed on B cells and in liver and kidney and is a receptor for H-ferritin endocytosis. J Exp Med 202(7):955\u2013965. doi: 10.1084\/jem.20042433","journal-title":"J Exp Med"},{"issue":"6","key":"9879_CR54","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1111\/j.1471-4159.2008.05678.x","volume":"107","author":"B Todorich","year":"2008","unstructured":"Todorich B, Zhang X, Slagle-Webb B, Seaman WE, Connor JR (2008) Tim-2 is the receptor for H-ferritin on oligodendrocytes. J Neurochem 107(6):1495\u20131505. doi: 10.1111\/j.1471-4159.2008.05678.x","journal-title":"J Neurochem"},{"issue":"2","key":"9879_CR55","doi-asserted-by":"publisher","first-page":"C641","DOI":"10.1152\/ajpcell.00599.2006","volume":"293","author":"J Fisher","year":"2007","unstructured":"Fisher J, Devraj K, Ingram J, Slagle-Webb B, Madhankumar AB, Liu X, Klinger M, Simpson IA, Connor JR (2007) Ferritin: a novel mechanism for delivery of iron to the brain and other organs. Am J Physiol Cell Physiol 293(2):C641\u2013C649. doi: 10.1152\/ajpcell.00599.2006","journal-title":"Am J Physiol Cell Physiol"},{"issue":"1","key":"9879_CR56","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.devcel.2008.12.002","volume":"16","author":"JY Li","year":"2009","unstructured":"Li JY, Paragas N, Ned RM, Qiu A, Viltard M, Leete T, Drexler IR, Chen X, Sanna-Cherchi S, Mohammed F, Williams D, Lin CS, Schmidt-Ott KM, Andrews NC, Barasch J (2009) Scara5 is a ferritin receptor mediating non-transferrin iron delivery. Dev Cell 16(1):35\u201346. doi: 10.1016\/j.devcel.2008.12.002","journal-title":"Dev Cell"},{"issue":"3","key":"9879_CR57","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.cmet.2005.02.005","volume":"1","author":"T Ganz","year":"2005","unstructured":"Ganz T (2005) Cellular iron: ferroportin is the only way out. Cell Metab 1(3):155\u2013157. doi: 10.1016\/j.cmet.2005.02.005","journal-title":"Cell Metab"},{"issue":"6771","key":"9879_CR58","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/35001691","volume":"403","author":"J Kaplan","year":"2000","unstructured":"Kaplan J, Kushner JP (2000) Mining the genome for iron. Nature 403(6771):711\u2013713. doi: 10.1038\/35001691","journal-title":"Nature"},{"issue":"2","key":"9879_CR59","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S1097-2765(00)80425-6","volume":"5","author":"AT McKie","year":"2000","unstructured":"McKie AT, Marciani P, Rolfs A, Brennan K, Wehr K, Barrow D, Miret S, Bomford A, Peters TJ, Farzaneh F, Hediger MA, Hentze MW, Simpson RJ (2000) A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell 5(2):299\u2013309","journal-title":"Mol Cell"},{"issue":"2","key":"9879_CR60","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S1357-2725(01)00104-2","volume":"34","author":"NT Le","year":"2002","unstructured":"Le NT, Richardson DR (2002) Ferroportin1: a new iron export molecule? Int J Biochem Cell Biol 34(2):103\u2013108","journal-title":"Int J Biochem Cell Biol"},{"issue":"2-3","key":"9879_CR61","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000065687","volume":"24","author":"DH Jiang","year":"2002","unstructured":"Jiang DH, Ke Y, Cheng YZ, Ho KP, Qian ZM (2002) Distribution of ferroportin1 protein in different regions of developing rat brain. Dev Neurosci 24(2-3):94\u201398","journal-title":"Dev Neurosci"},{"issue":"1-2","key":"9879_CR62","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.brainres.2003.10.066","volume":"1001","author":"LJ Wu","year":"2004","unstructured":"Wu LJ, Leenders AG, Cooperman S, Meyron-Holtz E, Smith S, Land W, Tsai RY, Berger UV, Sheng ZH, Rouault TA (2004) Expression of the iron transporter ferroportin in synaptic vesicles and the blood-brain barrier. Brain Res 1001(1-2):108\u2013117. doi: 10.1016\/j.brainres.2003.10.066","journal-title":"Brain Res"},{"issue":"9","key":"9879_CR63","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1111\/j.1460-9568.2007.05515.x","volume":"25","author":"J Wang","year":"2007","unstructured":"Wang J, Jiang H, Xie JX (2007) Ferroportin1 and hephaestin are involved in the nigral iron accumulation of 6-OHDA-lesioned rats. Eur J Neurosci 25(9):2766\u20132772. doi: 10.1111\/j.1460-9568.2007.05515.x","journal-title":"Eur J Neurosci"},{"issue":"5","key":"9879_CR64","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/ana.410370515","volume":"37","author":"H Morita","year":"1995","unstructured":"Morita H, Ikeda S, Yamamoto K, Morita S, Yoshida K, Nomoto S, Kato M, Yanagisawa N (1995) Hereditary ceruloplasmin deficiency with hemosiderosis: a clinicopathological study of a Japanese family. Ann Neurol 37(5):646\u2013656. doi: 10.1002\/ana.410370515","journal-title":"Ann Neurol"},{"issue":"3","key":"9879_CR65","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng0395-267","volume":"9","author":"K Yoshida","year":"1995","unstructured":"Yoshida K, Furihata K, Takeda S, Nakamura A, Yamamoto K, Morita H, Hiyamuta S, Ikeda S, Shimizu N, Yanagisawa N (1995) A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans. Nat Genet 9(3):267\u2013272. doi: 10.1038\/ng0395-267","journal-title":"Nat Genet"},{"issue":"5","key":"9879_CR66","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s10571-015-0161-2","volume":"35","author":"J Wang","year":"2015","unstructured":"Wang J, Bi M, Xie J (2015) Ceruloplasmin is Involved in the Nigral Iron Accumulation of 6-OHDA-Lesioned Rats. Cell Mol Neurobiol 35(5):661\u2013668. doi: 10.1007\/s10571-015-0161-2","journal-title":"Cell Mol Neurobiol"},{"issue":"3","key":"9879_CR67","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0304-3940(99)00221-9","volume":"265","author":"MC Boll","year":"1999","unstructured":"Boll MC, Sotelo J, Otero E, Alcaraz-Zubeldia M, Rios C (1999) Reduced ferroxidase activity in the cerebrospinal fluid from patients with Parkinson\u2019s disease. Neurosci Lett 265(3):155\u2013158","journal-title":"Neurosci Lett"},{"issue":"2","key":"9879_CR68","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/nm.2613","volume":"18","author":"P Lei","year":"2012","unstructured":"Lei P, Ayton S, Finkelstein DI, Spoerri L, Ciccotosto GD, Wright DK, Wong BX, Adlard PA, Cherny RA, Lam LQ, Roberts BR, Volitakis I, Egan GF, McLean CA, Cappai R, Duce JA, Bush AI (2012) Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export. Nat Med 18(2):291\u2013295. doi: 10.1038\/nm.2613","journal-title":"Nat Med"},{"issue":"6","key":"9879_CR69","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.cell.2010.08.014","volume":"142","author":"JA Duce","year":"2010","unstructured":"Duce JA, Tsatsanis A, Cater MA, James SA, Robb E, Wikhe K, Leong SL, Perez K, Johanssen T, Greenough MA, Cho HH, Galatis D, Moir RD, Masters CL, McLean C, Tanzi RE, Cappai R, Barnham KJ, Ciccotosto GD, Rogers JT, Bush AI (2010) Iron-export ferroxidase activity of beta-amyloid precursor protein is inhibited by zinc in Alzheimer\u2019s disease. Cell 142(6):857\u2013867. doi: 10.1016\/j.cell.2010.08.014","journal-title":"Cell"},{"issue":"7","key":"9879_CR70","doi-asserted-by":"crossref","first-page":"809","DOI":"10.15252\/embr.201338064","volume":"15","author":"RC McCarthy","year":"2014","unstructured":"McCarthy RC, Park YH, Kosman DJ (2014) sAPP modulates iron efflux from brain microvascular endothelial cells by stabilizing the ferrous iron exporter ferroportin. EMBO Rep 15(7):809\u2013815","journal-title":"EMBO Rep"},{"issue":"8","key":"9879_CR71","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.1523\/JNEUROSCI.3439-14.2015","volume":"35","author":"S Ayton","year":"2015","unstructured":"Ayton S, Lei P, Hare DJ, Duce JA, George JL, Adlard PA, McLean C, Rogers JT, Cherny RA, Finkelstein DI, Bush AI (2015) Parkinson\u2019s disease iron deposition caused by nitric oxide-induced loss of beta-amyloid precursor protein. J Neurosci 35(8):3591\u20133597. doi: 10.1523\/JNEUROSCI.3439-14.2015","journal-title":"J Neurosci"},{"issue":"3-4","key":"9879_CR72","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0162-0134(92)84071-T","volume":"47","author":"CM Morris","year":"1992","unstructured":"Morris CM, Candy JM, Keith AB, Oakley AE, Taylor GA, Pullen RG, Bloxham CA, Gocht A, Edwardson JA (1992) Brain iron homeostasis. J Inorg Biochem 47(3-4):257\u2013265","journal-title":"J Inorg Biochem"},{"issue":"5","key":"9879_CR73","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1006\/jmbi.1994.1325","volume":"238","author":"S Levi","year":"1994","unstructured":"Levi S, Santambrogio P, Cozzi A, Rovida E, Corsi B, Tamborini E, Spada S, Albertini A, Arosio P (1994) The role of the L-chain in ferritin iron incorporation. Studies of homo and heteropolymers. J Mol Biol 238(5):649\u2013654. doi: 10.1006\/jmbi.1994.1325","journal-title":"J Mol Biol"},{"issue":"1-2","key":"9879_CR74","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0014-5793(89)81040-3","volume":"254","author":"DM Lawson","year":"1989","unstructured":"Lawson DM, Treffry A, Artymiuk PJ, Harrison PM, Yewdall SJ, Luzzago A, Cesareni G, Levi S, Arosio P (1989) Identification of the ferroxidase centre in ferritin. FEBS Lett 254(1-2):207\u2013210","journal-title":"FEBS Lett"},{"issue":"1","key":"9879_CR75","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/(SICI)1096-9861(19981012)400:1<73::AID-CNE5>3.0.CO;2-Q","volume":"400","author":"P Cheepsunthorn","year":"1998","unstructured":"Cheepsunthorn P, Palmer C, Connor JR (1998) Cellular distribution of ferritin subunits in postnatal rat brain. J Comp Neurol 400(1):73\u201386. doi: 10.1002\/(SICI)1096-9861(19981012)400:1<73::AID-CNE5>3.0.CO;2-Q","journal-title":"J Comp Neurol"},{"issue":"4","key":"9879_CR76","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/jnr.490370405","volume":"37","author":"JR Connor","year":"1994","unstructured":"Connor JR, Boeshore KL, Benkovic SA, Menzies SL (1994) Isoforms of ferritin have a specific cellular distribution in the brain. J Neurosci Res 37(4):461\u2013465. doi: 10.1002\/jnr.490370405","journal-title":"J Neurosci Res"},{"issue":"7","key":"9879_CR77","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.bbagen.2008.08.005","volume":"1790","author":"AM Snyder","year":"2009","unstructured":"Snyder AM, Connor JR (2009) Iron, the substantia nigra and related neurological disorders. Biochim Biophys Acta 1790(7):606\u2013614. doi: 10.1016\/j.bbagen.2008.08.005","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"9879_CR78","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1093\/jn\/132.9.2769","volume":"132","author":"J Han","year":"2002","unstructured":"Han J, Day JR, Connor JR, Beard JL (2002) H and L ferritin subunit mRNA expression differs in brains of control and iron-deficient rats. J Nutr 132(9):2769\u20132774","journal-title":"J Nutr"},{"issue":"3","key":"9879_CR79","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1212\/01.WNL.0000078887.16593.12","volume":"61","author":"JR Connor","year":"2003","unstructured":"Connor JR, Boyer PJ, Menzies SL, Dellinger B, Allen RP, Ondo WG, Earley CJ (2003) Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology 61(3):304\u2013309","journal-title":"Neurology"},{"issue":"3","key":"9879_CR80","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0006-2952(03)00293-4","volume":"66","author":"KL Double","year":"2003","unstructured":"Double KL, Gerlach M, Schunemann V, Trautwein AX, Zecca L, Gallorini M, Youdim MB, Riederer P, Ben-Shachar D (2003) Iron-binding characteristics of neuromelanin of the human substantia nigra. Biochem Pharmacol 66(3):489\u2013494","journal-title":"Biochem Pharmacol"},{"issue":"8","key":"9879_CR81","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1074\/mcp.M900006-MCP200","volume":"8","author":"F Tribl","year":"2009","unstructured":"Tribl F, Asan E, Arzberger T, Tatschner T, Langenfeld E, Meyer HE, Bringmann G, Riederer P, Gerlach M, Marcus K (2009) Identification of L-ferritin in neuromelanin granules of the human substantia nigra: a targeted proteomics approach. Mol Cell Proteomics 8(8):1832\u20131838. doi: 10.1074\/mcp.M900006-MCP200","journal-title":"Mol Cell Proteomics"},{"issue":"2","key":"9879_CR82","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1089\/ars.2013.5593","volume":"21","author":"D Devos","year":"2014","unstructured":"Devos D, Moreau C, Devedjian JC, Kluza J, Petrault M, Laloux C, Jonneaux A, Ryckewaert G, Garcon G, Rouaix N, Duhamel A, Jissendi P, Dujardin K, Auger F, Ravasi L, Hopes L, Grolez G, Firdaus W, Sablonniere B, Strubi-Vuillaume I, Zahr N, Destee A, Corvol JC, Poltl D, Leist M, Rose C, Defebvre L, Marchetti P, Cabantchik ZI, Bordet R (2014) Targeting chelatable iron as a therapeutic modality in Parkinson\u2019s disease. Antioxid Redox Signal 21(2):195\u2013210. doi: 10.1089\/ars.2013.5593","journal-title":"Antioxid Redox Signal"},{"issue":"11","key":"9879_CR83","doi-asserted-by":"publisher","first-page":"7806","DOI":"10.1074\/jbc.M008922200","volume":"276","author":"CH Park","year":"2001","unstructured":"Park CH, Valore EV, Waring AJ, Ganz T (2001) Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 276(11):7806\u20137810. doi: 10.1074\/jbc.M008922200","journal-title":"J Biol Chem"},{"issue":"3","key":"9879_CR84","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1006\/bcmd.2002.0573","volume":"29","author":"G Nicolas","year":"2002","unstructured":"Nicolas G, Viatte L, Bennoun M, Beaumont C, Kahn A, Vaulont S (2002) Hepcidin, a new iron regulatory peptide. Blood Cells Mol Dis 29(3):327\u2013335","journal-title":"Blood Cells Mol Dis"},{"issue":"5704","key":"9879_CR85","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1126\/science.1104742","volume":"306","author":"E Nemeth","year":"2004","unstructured":"Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J (2004) Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306(5704):2090\u20132093. doi: 10.1126\/science.1104742","journal-title":"Science"},{"issue":"5","key":"9879_CR86","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1073\/pnas.0409409102","volume":"102","author":"MD Knutson","year":"2005","unstructured":"Knutson MD, Oukka M, Koss LM, Aydemir F, Wessling-Resnick M (2005) Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin. Proc Natl Acad Sci U S A 102(5):1324\u20131328. doi: 10.1073\/pnas.0409409102","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9879_CR87","doi-asserted-by":"publisher","unstructured":"Wang SM, Fu LJ, Duan XL, Crooks DR, Yu P, Qian ZM, Di XJ, Li J, Rouault TA, Chang YZ (2009) Role of hepcidin in murine brain iron metabolism. Cell Mol Life Sci. doi: 10.1007\/s00018-009-0167-3","DOI":"10.1007\/s00018-009-0167-3"},{"issue":"4","key":"9879_CR88","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1002\/jnr.20991","volume":"84","author":"S Zechel","year":"2006","unstructured":"Zechel S, Huber-Wittmer K, Von B, Halbach O (2006) Distribution of the iron-regulating protein hepcidin in the murine central nervous system. J Neurosci Res 84(4):790\u2013800. doi: 10.1002\/jnr.20991","journal-title":"J Neurosci Res"},{"key":"9879_CR89","doi-asserted-by":"publisher","unstructured":"Du F, Qian ZM, Luo Q, Yung WH, Ke Y (2014) Hepcidin Suppresses Brain Iron Accumulation by Downregulating Iron Transport Proteins in Iron-Overloaded Rats. Mol Neurobiol. doi: 10.1007\/s12035-014-8847-x","DOI":"10.1007\/s12035-014-8847-x"},{"issue":"10","key":"9879_CR90","doi-asserted-by":"publisher","first-page":"4268","DOI":"10.1182\/blood-2008-04-150953","volume":"112","author":"NJ Foot","year":"2008","unstructured":"Foot NJ, Dalton HE, Shearwin-Whyatt LM, Dorstyn L, Tan SS, Yang B, Kumar S (2008) Regulation of the divalent metal ion transporter DMT1 and iron homeostasis by a ubiquitin-dependent mechanism involving Ndfips and WWP2. Blood 112(10):4268\u20134275. doi: 10.1182\/blood-2008-04-150953","journal-title":"Blood"},{"issue":"39","key":"9879_CR91","doi-asserted-by":"crossref","first-page":"24252","DOI":"10.1016\/S0021-9258(19)51075-4","volume":"269","author":"B Guo","year":"1994","unstructured":"Guo B, Yu Y, Leibold EA (1994) Iron regulates cytoplasmic levels of a novel iron-responsive element-binding protein without aconitase activity. J Biol Chem 269(39):24252\u201324260","journal-title":"J Biol Chem"},{"issue":"35","key":"9879_CR92","doi-asserted-by":"crossref","first-page":"20509","DOI":"10.1074\/jbc.270.35.20509","volume":"270","author":"BR Henderson","year":"1995","unstructured":"Henderson BR, Kuhn LC (1995) Differential modulation of the RNA-binding proteins IRP-1 and IRP-2 in response to iron. IRP-2 inactivation requires translation of another protein. J Biol Chem 270(35):20509\u201320515","journal-title":"J Biol Chem"},{"issue":"1","key":"9879_CR93","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.bbrc.2008.07.061","volume":"375","author":"RF Regan","year":"2008","unstructured":"Regan RF, Li Z, Chen M, Zhang X, Chen-Roetling J (2008) Iron regulatory proteins increase neuronal vulnerability to hydrogen peroxide. Biochem Biophys Res Commun 375(1):6\u201310. doi: 10.1016\/j.bbrc.2008.07.061","journal-title":"Biochem Biophys Res Commun"},{"issue":"24","key":"9879_CR94","doi-asserted-by":"publisher","first-page":"10775","DOI":"10.1073\/pnas.0912925107","volume":"107","author":"DR Richardson","year":"2010","unstructured":"Richardson DR, Lane DJ, Becker EM, Huang ML, Whitnall M, Suryo Rahmanto Y, Sheftel AD, Ponka P (2010) Mitochondrial iron trafficking and the integration of iron metabolism between the mitochondrion and cytosol. Proc Natl Acad Sci U S A 107(24):10775\u201310782. doi: 10.1073\/pnas.0912925107","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9879_CR95","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1471-2121-11-39","volume":"11","author":"I Yanatori","year":"2010","unstructured":"Yanatori I, Tabuchi M, Kawai Y, Yasui Y, Akagi R, Kishi F (2010) Heme and non-heme iron transporters in non-polarized and polarized cells. BMC Cell Biol 11:39. doi: 10.1186\/1471-2121-11-39","journal-title":"BMC Cell Biol"},{"issue":"7","key":"9879_CR96","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1089\/ars.2010.3129","volume":"13","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Mikhael M, Xu D, Li Y, Soe-Lin S, Ning B, Li W, Nie G, Zhao Y, Ponka P (2010a) Lysosomal proteolysis is the primary degradation pathway for cytosolic ferritin and cytosolic ferritin degradation is necessary for iron exit. Antioxid Redox Signal 13(7):999\u20131009. doi: 10.1089\/ars.2010.3129","journal-title":"Antioxid Redox Signal"},{"key":"9879_CR97","doi-asserted-by":"crossref","unstructured":"Zhang J, Zhang Y, Wang J, Cai P, Luo C, Qian Z, Dai Y, Feng H (2010b) Characterizing iron deposition in Parkinson's disease using susceptibility-weighted imaging: an in vivo MR study. Brain Res 2010; 1330:124--130","DOI":"10.1016\/j.brainres.2010.03.036"},{"issue":"4","key":"9879_CR98","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s10534-012-9522-1","volume":"25","author":"MD Garrick","year":"2012","unstructured":"Garrick MD, Zhao L, Roth JA, Jiang H, Feng J, Foot NJ, Dalton H, Kumar S, Garrick LM (2012) Isoform specific regulation of divalent metal (ion) transporter (DMT1) by proteasomal degradation. Biometals 25(4):787\u2013793. doi: 10.1007\/s10534-012-9522-1","journal-title":"Biometals"},{"issue":"2","key":"9879_CR99","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1111\/j.1471-4159.2009.06165.x","volume":"110","author":"W Song","year":"2009","unstructured":"Song W, Patel A, Qureshi HY, Han D, Schipper HM, Paudel HK (2009) The Parkinson disease-associated A30P mutation stabilizes alpha-synuclein against proteasomal degradation triggered by heme oxygenase-1 over-expression in human neuroblastoma cells. J Neurochem 110(2):719\u2013733. doi: 10.1111\/j.1471-4159.2009.06165.x","journal-title":"J Neurochem"},{"issue":"7215","key":"9879_CR100","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1038\/nature07311","volume":"455","author":"XP Dong","year":"2008","unstructured":"Dong XP, Cheng X, Mills E, Delling M, Wang F, Kurz T, Xu H (2008) The type IV mucolipidosis-associated protein TRPML1 is an endolysosomal iron release channel. Nature 455(7215):992\u2013996. doi: 10.1038\/nature07311","journal-title":"Nature"},{"issue":"1","key":"9879_CR101","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1152\/physrev.00021.2006","volume":"87","author":"B Nilius","year":"2007","unstructured":"Nilius B, Owsianik G, Voets T, Peters JA (2007) Transient receptor potential cation channels in disease. Physiol Rev 87(1):165\u2013217. doi: 10.1152\/physrev.00021.2006","journal-title":"Physiol Rev"},{"issue":"1","key":"9879_CR102","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00424-005-1469-4","volume":"451","author":"F Qian","year":"2005","unstructured":"Qian F, Noben-Trauth K (2005) Cellular and molecular function of mucolipins (TRPML) and polycystin 2 (TRPP2). Pflugers Arch 451(1):277\u2013285. doi: 10.1007\/s00424-005-1469-4","journal-title":"Pflugers Arch"},{"issue":"17","key":"9879_CR103","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1093\/hmg\/9.17.2471","volume":"9","author":"M Sun","year":"2000","unstructured":"Sun M, Goldin E, Stahl S, Falardeau JL, Kennedy JC, Acierno JS Jr, Bove C, Kaneski CR, Nagle J, Bromley MC, Colman M, Schiffmann R, Slaugenhaupt SA (2000) Mucolipidosis type IV is caused by mutations in a gene encoding a novel transient receptor potential channel. Hum Mol Genet 9(17):2471\u20132478","journal-title":"Hum Mol Genet"},{"issue":"5","key":"9879_CR104","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1182\/blood-2004-10-3856","volume":"105","author":"I Napier","year":"2005","unstructured":"Napier I, Ponka P, Richardson DR (2005) Iron trafficking in the mitochondrion: novel pathways revealed by disease. Blood 105(5):1867\u20131874. doi: 10.1182\/blood-2004-10-3856","journal-title":"Blood"},{"issue":"1-2","key":"9879_CR105","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.cbi.2006.05.007","volume":"163","author":"XP Huang","year":"2006","unstructured":"Huang XP, O\u2019Brien PJ, Templeton DM (2006) Mitochondrial involvement in genetically determined transition metal toxicity I. Iron toxicity. Chem Biol Interact 163(1-2):68\u201376. doi: 10.1016\/j.cbi.2006.05.007","journal-title":"Chem Biol Interact"},{"issue":"3","key":"9879_CR106","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.nbd.2009.02.009","volume":"34","author":"PG Mastroberardino","year":"2009","unstructured":"Mastroberardino PG, Hoffman EK, Horowitz MP, Betarbet R, Taylor G, Cheng D, Na HM, Gutekunst CA, Gearing M, Trojanowski JQ, Anderson M, Chu CT, Peng J, Greenamyre JT (2009) A novel transferrin\/TfR2-mediated mitochondrial iron transport system is disrupted in Parkinson\u2019s disease. Neurobiol Dis 34(3):417\u2013431. doi: 10.1016\/j.nbd.2009.02.009","journal-title":"Neurobiol Dis"},{"key":"9879_CR107","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.nbd.2013.09.019","volume":"62","author":"SL Rhodes","year":"2014","unstructured":"Rhodes SL, Buchanan DD, Ahmed I, Taylor KD, Loriot MA, Sinsheimer JS, Bronstein JM, Elbaz A, Mellick GD, Rotter JI, Ritz B (2014) Pooled analysis of iron-related genes in Parkinson\u2019s disease: association with transferrin. Neurobiol Dis 62:172\u2013178. doi: 10.1016\/j.nbd.2013.09.019","journal-title":"Neurobiol Dis"},{"issue":"27","key":"9879_CR108","doi-asserted-by":"publisher","first-page":"24437","DOI":"10.1074\/jbc.C100141200","volume":"276","author":"S Levi","year":"2001","unstructured":"Levi S, Corsi B, Bosisio M, Invernizzi R, Volz A, Sanford D, Arosio P, Drysdale J (2001) A human mitochondrial ferritin encoded by an intronless gene. J Biol Chem 276(27):24437\u201324440. doi: 10.1074\/jbc.C100141200","journal-title":"J Biol Chem"},{"issue":"Pt 1","key":"9879_CR109","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1093\/brain\/awq319","volume":"134","author":"L Jin","year":"2011","unstructured":"Jin L, Wang J, Zhao L, Jin H, Fei G, Zhang Y, Zeng M, Zhong C (2011) Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson\u2019s disease. Brain 134(Pt 1):50\u201358. doi: 10.1093\/brain\/awq319","journal-title":"Brain"},{"issue":"15","key":"9879_CR110","doi-asserted-by":"publisher","first-page":"5893","DOI":"10.1073\/pnas.0601471103","volume":"103","author":"F Missirlis","year":"2006","unstructured":"Missirlis F, Holmberg S, Georgieva T, Dunkov BC, Rouault TA, Law JH (2006) Characterization of mitochondrial ferritin in Drosophila. Proc Natl Acad Sci U S A 103(15):5893\u20135898. doi: 10.1073\/pnas.0601471103","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"9879_CR111","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1089\/ars.2009.3018","volume":"13","author":"ZH Shi","year":"2010","unstructured":"Shi ZH, Nie G, Duan XL, Rouault T, Wu WS, Ning B, Zhang N, Chang YZ, Zhao BL (2010) Neuroprotective mechanism of mitochondrial ferritin on 6-hydroxydopamine-induced dopaminergic cell damage: implication for neuroprotection in Parkinson\u2019s disease. Antioxid Redox Signal 13(6):783\u2013796. doi: 10.1089\/ars.2009.3018","journal-title":"Antioxid Redox Signal"},{"issue":"7","key":"9879_CR112","doi-asserted-by":"publisher","first-page":"e65978","DOI":"10.1371\/journal.pone.0065978","volume":"8","author":"S Bandyopadhyay","year":"2013","unstructured":"Bandyopadhyay S, Cahill C, Balleidier A, Huang C, Lahiri DK, Huang X, Rogers JT (2013) Novel 5\u2019 untranslated region directed blockers of iron-regulatory protein-1 dependent amyloid precursor protein translation: implications for down syndrome and Alzheimer\u2019s disease. PLoS One 8(7):e65978. doi: 10.1371\/journal.pone.0065978","journal-title":"PLoS One"},{"key":"9879_CR113","doi-asserted-by":"crossref","unstructured":"Santambrogio P, Biasiotto G, Sanvito F, Olivieri S, Arosio P, Levi S (2007) Mitochondrial ferritin expression in adult mouse tissues. J Histochem Cytochem 55(11):1129\u20131137","DOI":"10.1369\/jhc.7A7273.2007"},{"issue":"3","key":"9879_CR114","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.jmb.2005.01.007","volume":"347","author":"F Bou-Abdallah","year":"2005","unstructured":"Bou-Abdallah F, Santambrogio P, Levi S, Arosio P, Chasteen ND (2005) Unique iron binding and oxidation properties of human mitochondrial ferritin: a comparative analysis with Human H-chain ferritin. J Mol Biol 347(3):543\u2013554. doi: 10.1016\/j.jmb.2005.01.007","journal-title":"J Mol Biol"},{"issue":"5","key":"9879_CR115","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1182\/blood-2004-07-2722","volume":"105","author":"G Nie","year":"2005","unstructured":"Nie G, Sheftel AD, Kim SF, Ponka P (2005) Overexpression of mitochondrial ferritin causes cytosolic iron depletion and changes cellular iron homeostasis. Blood 105(5):2161\u20132167. doi: 10.1182\/blood-2004-07-2722","journal-title":"Blood"},{"issue":"2","key":"9879_CR116","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1089\/ars.2011.4285","volume":"18","author":"WS Wu","year":"2013","unstructured":"Wu WS, Zhao YS, Shi ZH, Chang SY, Nie GJ, Duan XL, Zhao SM, Wu Q, Yang ZL, Zhao BL, Chang YZ (2013) Mitochondrial ferritin attenuates beta-amyloid-induced neurotoxicity: reduction in oxidative damage through the Erk\/P38 mitogen-activated protein kinase pathways. Antioxid Redox Signal 18(2):158\u2013169. doi: 10.1089\/ars.2011.4285","journal-title":"Antioxid Redox Signal"},{"issue":"12","key":"9879_CR117","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1016\/j.freeradbiomed.2004.09.015","volume":"37","author":"HM Schipper","year":"2004","unstructured":"Schipper HM (2004) Heme oxygenase expression in human central nervous system disorders. Free Radic Biol Med 37(12):1995\u20132011. doi: 10.1016\/j.freeradbiomed.2004.09.015","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"9879_CR118","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1046\/j.1471-4159.2001.00354.x","volume":"77","author":"K Mehindate","year":"2001","unstructured":"Mehindate K, Sahlas DJ, Frankel D, Mawal Y, Liberman A, Corcos J, Dion S, Schipper HM (2001) Proinflammatory cytokines promote glial heme oxygenase-1 expression and mitochondrial iron deposition: implications for multiple sclerosis. J Neurochem 77(5):1386\u20131395","journal-title":"J Neurochem"},{"issue":"3","key":"9879_CR119","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1006\/bbrc.1996.0135","volume":"218","author":"Y Lavrovsky","year":"1996","unstructured":"Lavrovsky Y, Drummond GS, Abraham NG (1996) Downregulation of the human heme oxygenase gene by glucocorticoids and identification of 56b regulatory elements. Biochem Biophys Res Commun 218(3):759\u2013765. doi: 10.1006\/bbrc.1996.0135","journal-title":"Biochem Biophys Res Commun"},{"issue":"50","key":"9879_CR120","doi-asserted-by":"crossref","first-page":"16440","DOI":"10.1021\/bi00050a027","volume":"34","author":"KM Broekemeier","year":"1995","unstructured":"Broekemeier KM, Pfeiffer DR (1995) Inhibition of the mitochondrial permeability transition by cyclosporin A during long time frame experiments: relationship between pore opening and the activity of mitochondrial phospholipases. Biochemistry 34(50):16440\u201316449","journal-title":"Biochemistry"},{"issue":"29","key":"9879_CR121","doi-asserted-by":"crossref","first-page":"21939","DOI":"10.1016\/S0021-9258(20)80631-0","volume":"268","author":"V Petronilli","year":"1993","unstructured":"Petronilli V, Cola C, Massari S, Colonna R, Bernardi P (1993) Physiological effectors modify voltage sensing by the cyclosporin A-sensitive permeability transition pore of mitochondria. J Biol Chem 268(29):21939\u201321945","journal-title":"J Biol Chem"},{"issue":"10","key":"9879_CR122","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1002\/jnr.21367","volume":"85","author":"L Song","year":"2007","unstructured":"Song L, Song W, Schipper HM (2007) Astroglia overexpressing heme oxygenase-1 predispose co-cultured PC12 cells to oxidative injury. J Neurosci Res 85(10):2186\u20132195. doi: 10.1002\/jnr.21367","journal-title":"J Neurosci Res"},{"key":"9879_CR123","doi-asserted-by":"crossref","unstructured":"Riederer P, Sofic E, Rausch WD, Schmidt B, Reynolds GP, Jellinger K, Youdim MB (1989) Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J Neurochem 52(2):515\u2013520","DOI":"10.1111\/j.1471-4159.1989.tb09150.x"},{"key":"9879_CR124","doi-asserted-by":"crossref","unstructured":"Mann VM, Cooper JM, Daniel SE, Srai K, Jenner P, Marsden CD, Schapira AH (1994) Complex I, iron, and ferritin in Parkinson's disease substantia nigra. Ann Neurol 36(6):876\u2013881","DOI":"10.1002\/ana.410360612"},{"key":"9879_CR125","doi-asserted-by":"crossref","unstructured":"Griffiths PD, Dobson BR, Jones GR, Clarke DT (1999) Iron in the basal ganglia in Parkinson's disease. An in vitro study using extended X-ray absorption fine structure and cryo-electron microscopy. Brain 122(4):667\u2013673","DOI":"10.1093\/brain\/122.4.667"},{"key":"9879_CR126","doi-asserted-by":"crossref","unstructured":"Jellinger K, Kienzl E, Rumpelmair G, Riederer P, Stachelberger H, Ben-Shachar D, Youdim MB (1992) Iron-melanin complex in substantia nigra of parkinsonian brains: an x-ray microanalysis. J Neurochem 59(3):1168\u20131171","DOI":"10.1111\/j.1471-4159.1992.tb08362.x"},{"key":"9879_CR127","doi-asserted-by":"crossref","unstructured":"Berg, D., Roggendorf, W., Schroder, U., Klein, R., Tatschner, T., Benz, P., Tucha, O., Preier, M., Lange, K. W., Reiners, K., Gerlach, M. and Becker, G. (2002) Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury. Arch Neurol 59:999\u20131005","DOI":"10.1001\/archneur.59.6.999"},{"issue":"6","key":"9879_CR128","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0896-6273(03)00126-0","volume":"37","author":"D Kaur","year":"2003","unstructured":"Kaur D, Yantiri F, Rajagopalan S, Kumar J, Mo JQ, Boonplueang R, Viswanath V, Jacobs R, Yang L, Beal MF, DiMonte D, Volitaskis I, Ellerby L, Cherny RA, Bush AI, Andersen JK (2003) Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson\u2019s disease. Neuron 37(6):899\u2013909","journal-title":"Neuron"},{"issue":"8","key":"9879_CR129","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1038\/sj.bjp.0706416","volume":"146","author":"A Gaeta","year":"2005","unstructured":"Gaeta A, Hider RC (2005) The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy. Br J Pharmacol 146(8):1041\u20131059. doi: 10.1038\/sj.bjp.0706416","journal-title":"Br J Pharmacol"},{"issue":"14","key":"9879_CR130","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.1096\/fj.07-8386com","volume":"21","author":"W Zhu","year":"2007","unstructured":"Zhu W, Xie W, Pan T, Xu P, Fridkin M, Zheng H, Jankovic J, Youdim MB, Le W (2007) Prevention and restoration of lactacystin-induced nigrostriatal dopamine neuron degeneration by novel brain-permeable iron chelators. FASEB J 21(14):3835\u20133844. doi: 10.1096\/fj.07-8386com","journal-title":"FASEB J"},{"key":"9879_CR131","first-page":"V","volume":"71","author":"MB Youdim","year":"2006","unstructured":"Youdim MB (2006) My love with monoamine oxidase, iron and Parkinson\u2019s disease. J Neural Transm Suppl 71:V\u2013IX","journal-title":"J Neural Transm Suppl"},{"key":"9879_CR132","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1750-1326-9-27","volume":"9","author":"S Ayton","year":"2014","unstructured":"Ayton S, Lei P, Adlard PA, Volitakis I, Cherny RA, Bush AI, Finkelstein DI (2014) Iron accumulation confers neurotoxicity to a vulnerable population of nigral neurons: implications for Parkinson\u2019s disease. Mol Neurodegener 9:27. doi: 10.1186\/1750-1326-9-27","journal-title":"Mol Neurodegener"},{"issue":"3","key":"9879_CR133","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF01244786","volume":"74","author":"E Sofic","year":"1988","unstructured":"Sofic E, Riederer P, Heinsen H, Beckmann H, Reynolds GP, Hebenstreit G, Youdim MB (1988) Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain. J Neural Transm 74(3):199\u2013205","journal-title":"J Neural Transm"},{"issue":"3","key":"9879_CR134","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1471-4159.1991.tb02017.x","volume":"56","author":"E Sofic","year":"1991","unstructured":"Sofic E, Paulus W, Jellinger K, Riederer P, Youdim MB (1991) Selective increase of iron in substantia nigra zona compacta of parkinsonian brains. J Neurochem 56(3):978\u2013982","journal-title":"J Neurochem"},{"issue":"Pt 4","key":"9879_CR135","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/brain\/114.4.1953","volume":"114","author":"DT Dexter","year":"1991","unstructured":"Dexter DT, Carayon A, Javoy-Agid F, Agid Y, Wells FR, Daniel SE, Lees AJ, Jenner P, Marsden CD (1991) Alterations in the levels of iron, ferritin and other trace metals in Parkinson\u2019s disease and other neurodegenerative diseases affecting the basal ganglia. Brain 114(Pt 4):1953\u20131975","journal-title":"Brain"},{"issue":"2","key":"9879_CR136","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1148\/radiology.159.2.3961182","volume":"159","author":"BP Drayer","year":"1986","unstructured":"Drayer BP, Olanow W, Burger P, Johnson GA, Herfkens R, Riederer S (1986) Parkinson plus syndrome: diagnosis using high field MR imaging of brain iron. Radiology 159(2):493\u2013498","journal-title":"Radiology"},{"issue":"6","key":"9879_CR137","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1001\/archneur.1995.00540300057013","volume":"52","author":"P Ryvlin","year":"1995","unstructured":"Ryvlin P, Broussolle E, Piollet H, Viallet F, Khalfallah Y, Chazot G (1995) Magnetic resonance imaging evidence of decreased putamenal iron content in idiopathic Parkinson\u2019s disease. Arch Neurol 52(6):583\u2013588","journal-title":"Arch Neurol"},{"issue":"2","key":"9879_CR138","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0006-8993(92)91334-B","volume":"593","author":"PF Good","year":"1992","unstructured":"Good PF, Olanow CW, Perl DP (1992) Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson\u2019s disease: a LAMMA study. Brain Res 593(2):343\u2013346","journal-title":"Brain Res"},{"issue":"4","key":"9879_CR139","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.bcp.2014.01.032","volume":"88","author":"S Bandyopadhyay","year":"2014","unstructured":"Bandyopadhyay S, Rogers JT (2014) Alzheimer\u2019s disease therapeutics targeted to the control of amyloid precursor protein translation: maintenance of brain iron homeostasis. Biochem Pharmacol 88(4):486\u2013494. doi: 10.1016\/j.bcp.2014.01.032","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"9879_CR140","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.clinimag.2013.02.001","volume":"37","author":"M Rossi","year":"2013","unstructured":"Rossi M, Ruottinen H, Soimakallio S, Elovaara I, Dastidar P (2013) Clinical MRI for iron detection in Parkinson\u2019s disease. Clin Imaging 37(4):631\u2013636. doi: 10.1016\/j.clinimag.2013.02.001","journal-title":"Clin Imaging"},{"issue":"7","key":"9879_CR141","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.mri.2013.04.015","volume":"31","author":"C Wang","year":"2013","unstructured":"Wang C, Fan G, Xu K, Wang S (2013) Quantitative assessment of iron deposition in the midbrain using 3D-enhanced T2 star weighted angiography (ESWAN): a preliminary cross-sectional study of 20 Parkinson\u2019s disease patients. Magn Reson Imaging 31(7):1068\u20131073. doi: 10.1016\/j.mri.2013.04.015","journal-title":"Magn Reson Imaging"},{"issue":"5","key":"9879_CR142","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.mri.2015.02.021","volume":"33","author":"JH Barbosa","year":"2015","unstructured":"Barbosa JH, Santos AC, Tumas V, Liu M, Zheng W, Haacke EM, Salmon CE (2015) Quantifying brain iron deposition in patients with Parkinson\u2019s disease using quantitative susceptibility mapping, R2 and R2. Magn Reson Imaging 33(5):559\u2013565. doi: 10.1016\/j.mri.2015.02.021","journal-title":"Magn Reson Imaging"},{"issue":"6","key":"9879_CR143","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s00702-005-0447-5","volume":"113","author":"D Berg","year":"2006","unstructured":"Berg D (2006) In vivo detection of iron and neuromelanin by transcranial sonography--a new approach for early detection of substantia nigra damage. J Neural Transm 113(6):775\u2013780. doi: 10.1007\/s00702-005-0447-5","journal-title":"J Neural Transm"},{"issue":"5","key":"9879_CR144","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1002\/jmri.21563","volume":"28","author":"LI Wallis","year":"2008","unstructured":"Wallis LI, Paley MN, Graham JM, Grunewald RA, Wignall EL, Joy HM, Griffiths PD (2008) MRI assessment of basal ganglia iron deposition in Parkinson\u2019s disease. J Magn Reson Imaging 28(5):1061\u20131067. doi: 10.1002\/jmri.21563","journal-title":"J Magn Reson Imaging"},{"key":"9879_CR145","doi-asserted-by":"publisher","unstructured":"Pavese N, Brooks DJ (2008) Imaging neurodegeneration in Parkinson\u2019s disease. Biochimica et biophysica acta. doi: 10.1016\/j.bbadis.2008.10.003","DOI":"10.1016\/j.bbadis.2008.10.003"},{"issue":"16 Pt 2","key":"9879_CR146","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1212\/01.wnl.0000286384.31050.b5","volume":"70","author":"WR Martin","year":"2008","unstructured":"Martin WR, Wieler M, Gee M (2008) Midbrain iron content in early Parkinson disease: a potential biomarker of disease status. Neurology 70(16 Pt 2):1411\u20131417. doi: 10.1212\/01.wnl.0000286384.31050.b5","journal-title":"Neurology"},{"issue":"7","key":"9879_CR147","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.bbadis.2008.10.003","volume":"1792","author":"N Pavese","year":"2009","unstructured":"Pavese N, Brooks DJ (2009) Imaging neurodegeneration in Parkinson\u2019s disease. Biochim Biophys Acta 1792(7):722\u2013729. doi: 10.1016\/j.bbadis.2008.10.003","journal-title":"Biochim Biophys Acta"},{"issue":"18","key":"9879_CR148","first-page":"2605","volume":"18","author":"SF Wu","year":"2014","unstructured":"Wu SF, Zhu ZF, Kong Y, Zhang HP, Zhou GQ, Jiang QT, Meng XP (2014) Assessment of cerebral iron content in patients with Parkinson\u2019s disease by the susceptibility-weighted MRI. Eur Rev Med Pharmacol Sci 18(18):2605\u20132608","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"5","key":"9879_CR149","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1212\/WNL.0b013e31827f0ebb","volume":"80","author":"X Yu","year":"2013","unstructured":"Yu X, Du T, Song N, He Q, Shen Y, Jiang H, Xie J (2013) Decreased iron levels in the temporal cortex in postmortem human brains with Parkinson disease. Neurology 80(5):492\u2013495. doi: 10.1212\/WNL.0b013e31827f0ebb","journal-title":"Neurology"},{"issue":"2-3","key":"9879_CR150","first-page":"239","volume":"20","author":"JM Gorell","year":"1999","unstructured":"Gorell JM, Johnson CC, Rybicki BA, Peterson EL, Kortsha GX, Brown GG, Richardson RJ (1999) Occupational exposure to manganese, copper, lead, iron, mercury and zinc and the risk of Parkinson\u2019s disease. Neurotoxicology 20(2-3):239\u2013247","journal-title":"Neurotoxicology"},{"issue":"11","key":"9879_CR151","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1212\/01.WNL.0000068021.13945.7F","volume":"60","author":"KM Powers","year":"2003","unstructured":"Powers KM, Smith-Weller T, Franklin GM, Longstreth WT Jr, Swanson PD, Checkoway H (2003) Parkinson\u2019s disease risks associated with dietary iron, manganese, and other nutrient intakes. Neurology 60(11):1761\u20131766","journal-title":"Neurology"},{"issue":"12","key":"9879_CR152","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1093\/aje\/kwn273","volume":"168","author":"G Logroscino","year":"2008","unstructured":"Logroscino G, Gao X, Chen H, Wing A, Ascherio A (2008) Dietary iron intake and risk of Parkinson\u2019s disease. Am J Epidemiol 168(12):1381\u20131388. doi: 10.1093\/aje\/kwn273","journal-title":"Am J Epidemiol"},{"issue":"1","key":"9879_CR153","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.parkreldis.2008.03.002","volume":"15","author":"KM Powers","year":"2009","unstructured":"Powers KM, Smith-Weller T, Franklin GM, Longstreth WT Jr, Swanson PD, Checkoway H (2009) Dietary fats, cholesterol and iron as risk factors for Parkinson\u2019s disease. Parkinsonism Relat Disord 15(1):47\u201352. doi: 10.1016\/j.parkreldis.2008.03.002","journal-title":"Parkinsonism Relat Disord"},{"issue":"11","key":"9879_CR154","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1097\/WNR.0b013e32821c51fe","volume":"18","author":"ZG Ma","year":"2007","unstructured":"Ma ZG, Wang J, Jiang H, Liu TW, Xie JX (2007) Myricetin reduces 6-hydroxydopamine-induced dopamine neuron degeneration in rats. Neuroreport 18(11):1181\u20131185. doi: 10.1097\/WNR.0b013e32821c51fe","journal-title":"Neuroreport"},{"issue":"12","key":"9879_CR155","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1007\/s11064-004-7031-5","volume":"29","author":"J Wang","year":"2004","unstructured":"Wang J, Jiang H, Xie JX (2004) Time dependent effects of 6-OHDA lesions on iron level and neuronal loss in rat nigrostriatal system. Neurochem Res 29(12):2239\u20132243","journal-title":"Neurochem Res"},{"issue":"1","key":"9879_CR156","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.neuint.2008.10.003","volume":"54","author":"J Wang","year":"2009","unstructured":"Wang J, Xu HM, Yang HD, Du XX, Jiang H, Xie JX (2009) Rg1 reduces nigral iron levels of MPTP-treated C57BL6 mice by regulating certain iron transport proteins. Neurochem Int 54(1):43\u201348. doi: 10.1016\/j.neuint.2008.10.003","journal-title":"Neurochem Int"},{"key":"9879_CR157","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/978-3-7091-0643-3_5","volume":"65","author":"MB Youdim","year":"2003","unstructured":"Youdim MB (2003) What have we learnt from CDNA microarray gene expression studies about the role of iron in MPTP induced neurodegeneration and Parkinson\u2019s disease? J Neural Transm Suppl 65:73\u201388","journal-title":"J Neural Transm Suppl"},{"issue":"7-8","key":"9879_CR158","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1080\/1029842021000045507","volume":"4","author":"MB Youdim","year":"2002","unstructured":"Youdim MB, Grunblatt E, Levites Y, Maor G, Mandel S (2002) Early and late molecular events in neurodegeneration and neuroprotection in Parkinson\u2019s disease MPTP model as assessed by cDNA microarray; the role of iron. Neurotox Res 4(7-8):679\u2013689. doi: 10.1080\/1029842021000045507","journal-title":"Neurotox Res"},{"issue":"2","key":"9879_CR159","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1039\/c2mt20164j","volume":"5","author":"DJ Hare","year":"2013","unstructured":"Hare DJ, Adlard PA, Doble PA, Finkelstein DI (2013) Metallobiology of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity. Metallomics 5(2):91\u2013109. doi: 10.1039\/c2mt20164j","journal-title":"Metallomics"},{"issue":"3","key":"9879_CR160","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.neuroscience.2005.06.049","volume":"135","author":"J Zhang","year":"2005","unstructured":"Zhang J, Stanton DM, Nguyen XV, Liu M, Zhang Z, Gash D, Bing G (2005) Intrapallidal lipopolysaccharide injection increases iron and ferritin levels in glia of the rat substantia nigra and induces locomotor deficits. Neuroscience 135(3):829\u2013838. doi: 10.1016\/j.neuroscience.2005.06.049","journal-title":"Neuroscience"},{"issue":"26","key":"9879_CR161","doi-asserted-by":"publisher","first-page":"6914","DOI":"10.1523\/JNEUROSCI.1569-07.2007","volume":"27","author":"J Peng","year":"2007","unstructured":"Peng J, Peng L, Stevenson FF, Doctrow SR, Andersen JK (2007) Iron and paraquat as synergistic environmental risk factors in sporadic Parkinson\u2019s disease accelerate age-related neurodegeneration. J Neurosci 27(26):6914\u20136922. doi: 10.1523\/JNEUROSCI.1569-07.2007","journal-title":"J Neurosci"},{"issue":"2","key":"9879_CR162","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.freeradbiomed.2008.10.045","volume":"46","author":"J Peng","year":"2009","unstructured":"Peng J, Stevenson FF, Oo ML, Andersen JK (2009) Iron-enhanced paraquat-mediated dopaminergic cell death due to increased oxidative stress as a consequence of microglial activation. Free Radic Biol Med 46(2):312\u2013320. doi: 10.1016\/j.freeradbiomed.2008.10.045","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"9879_CR163","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0014-4886(03)00123-7","volume":"182","author":"X Junxia","year":"2003","unstructured":"Junxia X, Hong J, Wenfang C, Ming Q (2003) Dopamine release rather than content in the caudate putamen is associated with behavioral changes in the iron rat model of Parkinson\u2019s disease. Exp Neurol 182(2):483\u2013489","journal-title":"Exp Neurol"},{"issue":"6","key":"9879_CR164","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1111\/j.1471-4159.1991.tb06432.x","volume":"57","author":"D Ben-Shachar","year":"1991","unstructured":"Ben-Shachar D, Youdim MB (1991) Intranigral iron injection induces behavioral and biochemical \u201cparkinsonism\u201d in rats. J Neurochem 57(6):2133\u20132135","journal-title":"J Neurochem"},{"issue":"1","key":"9879_CR165","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.neuint.2007.03.006","volume":"51","author":"H Jiang","year":"2007","unstructured":"Jiang H, Song N, Wang J, Ren LY, Xie JX (2007) Peripheral iron dextran induced degeneration of dopaminergic neurons in rat substantia nigra. Neurochem Int 51(1):32\u201336. doi: 10.1016\/j.neuint.2007.03.006","journal-title":"Neurochem Int"},{"issue":"6","key":"9879_CR166","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.neuint.2006.04.015","volume":"49","author":"H Jiang","year":"2006","unstructured":"Jiang H, Luan Z, Wang J, Xie J (2006) Neuroprotective effects of iron chelator Desferal on dopaminergic neurons in the substantia nigra of rats with iron-overload. Neurochem Int 49(6):605\u2013609. doi: 10.1016\/j.neuint.2006.04.015","journal-title":"Neurochem Int"},{"issue":"1","key":"9879_CR167","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1006\/taap.1999.8711","volume":"159","author":"A Fredriksson","year":"1999","unstructured":"Fredriksson A, Schroder N, Eriksson P, Izquierdo I, Archer T (1999) Neonatal iron exposure induces neurobehavioural dysfunctions in adult mice. Toxicol Appl Pharmacol 159(1):25\u201330. doi: 10.1006\/taap.1999.8711","journal-title":"Toxicol Appl Pharmacol"},{"issue":"6","key":"9879_CR168","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.neurobiolaging.2006.04.003","volume":"28","author":"D Kaur","year":"2007","unstructured":"Kaur D, Peng J, Chinta SJ, Rajagopalan S, Di Monte DA, Cherny RA, Andersen JK (2007) Increased murine neonatal iron intake results in Parkinson-like neurodegeneration with age. Neurobiol Aging 28(6):907\u2013913. doi: 10.1016\/j.neurobiolaging.2006.04.003","journal-title":"Neurobiol Aging"},{"key":"9879_CR169","doi-asserted-by":"crossref","unstructured":"Faucheux BA, Hirsch EC, Villares J, Selimi F, Mouatt-Prigent A, Javoy-Agid F, Hauw JJ, Agid Y (1993) Distribution of 125I-ferrotransferrin binding sites in the mesencephalon of control subjects and patients with Parkinson's disease. J Neurochem 60: 2338\u20132341","DOI":"10.1111\/j.1471-4159.1993.tb03527.x"},{"issue":"1","key":"9879_CR170","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0006-8993(96)01412-6","volume":"749","author":"BA Faucheux","year":"1997","unstructured":"Faucheux BA, Hauw JJ, Agid Y, Hirsch EC (1997) The density of [125I]-transferrin binding sites on perikarya of melanized neurons of the substantia nigra is decreased in Parkinson\u2019s disease. Brain Res 749(1):170\u2013174","journal-title":"Brain Res"},{"issue":"Pt 1","key":"9879_CR171","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1042\/BJ20021525","volume":"371","author":"SV Kalivendi","year":"2003","unstructured":"Kalivendi SV, Kotamraju S, Cunningham S, Shang T, Hillard CJ, Kalyanaraman B (2003) 1-Methyl-4-phenylpyridinium (MPP+)-induced apoptosis and mitochondrial oxidant generation: role of transferrin-receptor-dependent iron and hydrogen peroxide. Biochem J 371(Pt 1):151\u2013164. doi: 10.1042\/BJ20021525","journal-title":"Biochem J"},{"issue":"5","key":"9879_CR172","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.freeradbiomed.2008.11.012","volume":"46","author":"D Kaur","year":"2009","unstructured":"Kaur D, Lee D, Ragapolan S, Andersen JK (2009) Glutathione depletion in immortalized midbrain-derived dopaminergic neurons results in increases in the labile iron pool: implications for Parkinson\u2019s disease. Free Radic Biol Med 46(5):593\u2013598. doi: 10.1016\/j.freeradbiomed.2008.11.012","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"9879_CR173","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/j.1471-4159.2009.06470.x","volume":"112","author":"DW Lee","year":"2010","unstructured":"Lee DW, Andersen JK (2010) Iron elevations in the aging Parkinsonian brain: a consequence of impaired iron homeostasis? J Neurochem 112(2):332\u2013339. doi: 10.1111\/j.1471-4159.2009.06470.x","journal-title":"J Neurochem"},{"issue":"3","key":"9879_CR174","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.neuroscience.2004.06.055","volume":"128","author":"E Huang","year":"2004","unstructured":"Huang E, Ong WY, Connor JR (2004) Distribution of divalent metal transporter-1 in the monkey basal ganglia. Neuroscience 128(3):487\u2013496. doi: 10.1016\/j.neuroscience.2004.06.055","journal-title":"Neuroscience"},{"issue":"47","key":"9879_CR175","doi-asserted-by":"publisher","first-page":"18578","DOI":"10.1073\/pnas.0804373105","volume":"105","author":"J Salazar","year":"2008","unstructured":"Salazar J, Mena N, Hunot S, Prigent A, Alvarez-Fischer D, Arredondo M, Duyckaerts C, Sazdovitch V, Zhao L, Garrick LM, Nunez MT, Garrick MD, Raisman-Vozari R, Hirsch EC (2008) Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson\u2019s disease. Proc Natl Acad Sci U S A 105(47):18578\u201318583. doi: 10.1073\/pnas.0804373105","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"9879_CR176","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/713609332","volume":"40","author":"J Chung","year":"2003","unstructured":"Chung J, Wessling-Resnick M (2003) Molecular mechanisms and regulation of iron transport. Crit Rev Clin Lab Sci 40(2):151\u2013182","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"2","key":"9879_CR177","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0014-5793(01)03189-1","volume":"509","author":"H Gunshin","year":"2001","unstructured":"Gunshin H, Allerson CR, Polycarpou-Schwarz M, Rofts A, Rogers JT, Kishi F, Hentze MW, Rouault TA, Andrews NC, Hediger MA (2001) Iron-dependent regulation of the divalent metal ion transporter. FEBS Lett 509(2):309\u2013316","journal-title":"FEBS Lett"},{"key":"9879_CR178","doi-asserted-by":"publisher","unstructured":"Song N, Wang J, Jiang H, Xie J Ferroportin 1 but not hephaestin contributes to iron accumulation in a cell model of Parkinson's disease. Free Radic Biol Med 48 (2):332-341. doi: 10.1016\/j.freeradbiomed.2009.11.004","DOI":"10.1016\/j.freeradbiomed.2009.11.004"},{"issue":"5","key":"9879_CR179","first-page":"571","volume":"55","author":"H Jiang","year":"2003","unstructured":"Jiang H, Qian ZM, Xie JX (2003) Increased DMT1 expression and iron content in MPTP-treated C57BL\/6 mice. Sheng Li Xue Bao 55(5):571\u2013576","journal-title":"Sheng Li Xue Bao"},{"issue":"42","key":"9879_CR180","doi-asserted-by":"publisher","first-page":"29065","DOI":"10.1074\/jbc.M109.000638","volume":"284","author":"DW Lee","year":"2009","unstructured":"Lee DW, Rajagopalan S, Siddiq A, Gwiazda R, Yang L, Beal MF, Ratan RR, Andersen JK (2009) Inhibition of prolyl hydroxylase protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity: model for the potential involvement of the hypoxia-inducible factor pathway in Parkinson disease. J Biol Chem 284(42):29065\u201329076. doi: 10.1074\/jbc.M109.000638","journal-title":"J Biol Chem"},{"key":"9879_CR181","doi-asserted-by":"publisher","unstructured":"Xu H, Jiang H, Wang J, Xie J (2009) Rg1 protects the MPP(+)-treated MES23.5 cells via attenuating DMT1 up-regulation and cellular iron uptake. Neuropharmacology. doi: 10.1016\/j.neuropharm.2009.09.002","DOI":"10.1016\/j.neuropharm.2009.09.002"},{"issue":"9","key":"9879_CR182","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1016\/j.neurobiolaging.2007.11.025","volume":"30","author":"S Zhang","year":"2009","unstructured":"Zhang S, Wang J, Song N, Xie J, Jiang H (2009) Up-regulation of divalent metal transporter 1 is involved in 1-methyl-4-phenylpyridinium (MPP(+))-induced apoptosis in MES23.5 cells. Neurobiol Aging 30(9):1466\u20131476. doi: 10.1016\/j.neurobiolaging.2007.11.025","journal-title":"Neurobiol Aging"},{"issue":"6","key":"9879_CR183","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.neuint.2007.10.019","volume":"52","author":"HM Xu","year":"2008","unstructured":"Xu HM, Jiang H, Wang J, Luo B, Xie JX (2008) Over-expressed human divalent metal transporter 1 is involved in iron accumulation in MES23.5 cells. Neurochem Int 52(6):1044\u20131051. doi: 10.1016\/j.neuint.2007.10.019","journal-title":"Neurochem Int"},{"issue":"3","key":"9879_CR184","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0166-3542(01)00195-4","volume":"52","author":"BW Strate van der","year":"2001","unstructured":"van der Strate BW, Beljaars L, Molema G, Harmsen MC, Meijer DK (2001) Antiviral activities of lactoferrin. Antiviral Res 52(3):225\u2013239","journal-title":"Antiviral Res"},{"issue":"1-2","key":"9879_CR185","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0169-328X(01)00216-9","volume":"96","author":"C Fillebeen","year":"2001","unstructured":"Fillebeen C, Ruchoux MM, Mitchell V, Vincent S, Benaissa M, Pierce A (2001) Lactoferrin is synthesized by activated microglia in the human substantia nigra and its synthesis by the human microglial CHME cell line is upregulated by tumor necrosis factor alpha or 1-methyl-4-phenylpyridinium treatment. Brain Res Mol Brain Res 96(1-2):103\u2013113","journal-title":"Brain Res Mol Brain Res"},{"issue":"2","key":"9879_CR186","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0169-328X(99)00221-1","volume":"72","author":"C Fillebeen","year":"1999","unstructured":"Fillebeen C, Mitchell V, Dexter D, Benaissa M, Beauvillain J, Spik G, Pierce A (1999) Lactoferrin is synthesized by mouse brain tissue and its expression is enhanced after MPTP treatment. Brain Res Mol Brain Res 72(2):183\u2013194","journal-title":"Brain Res Mol Brain Res"},{"issue":"6","key":"9879_CR187","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s004010050468","volume":"91","author":"B Leveugle","year":"1996","unstructured":"Leveugle B, Faucheux BA, Bouras C, Nillesse N, Spik G, Hirsch EC, Agid Y, Hof PR (1996) Cellular distribution of the iron-binding protein lactotransferrin in the mesencephalon of Parkinson\u2019s disease cases. Acta Neuropathol 91(6):566\u2013572","journal-title":"Acta Neuropathol"},{"issue":"21","key":"9879_CR188","doi-asserted-by":"crossref","first-page":"9603","DOI":"10.1073\/pnas.92.21.9603","volume":"92","author":"BA Faucheux","year":"1995","unstructured":"Faucheux BA, Nillesse N, Damier P, Spik G, Mouatt-Prigent A, Pierce A, Leveugle B, Kubis N, Hauw JJ, Agid Y et al (1995) Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson disease. Proc Natl Acad Sci U S A 92(21):9603\u20139607","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"9879_CR189","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1038\/sj.emboj.7601735","volume":"26","author":"I Domenico De","year":"2007","unstructured":"De Domenico I, Ward DM, di Patti MC, Jeong SY, David S, Musci G, Kaplan J (2007) Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin. EMBO J 26(12):2823\u20132831. doi: 10.1038\/sj.emboj.7601735","journal-title":"EMBO J"},{"issue":"38","key":"9879_CR190","doi-asserted-by":"publisher","first-page":"13850","DOI":"10.1073\/pnas.0405146101","volume":"101","author":"P Hahn","year":"2004","unstructured":"Hahn P, Qian Y, Dentchev T, Chen L, Beard J, Harris ZL, Dunaief JL (2004) Disruption of ceruloplasmin and hephaestin in mice causes retinal iron overload and retinal degeneration with features of age-related macular degeneration. Proc Natl Acad Sci U S A 101(38):13850\u201313855. doi: 10.1073\/pnas.0405146101","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"9879_CR191","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.neulet.2008.08.089","volume":"446","author":"K Kaneko","year":"2008","unstructured":"Kaneko K, Hineno A, Yoshida K, Ikeda S (2008) Increased vulnerability to rotenone-induced neurotoxicity in ceruloplasmin-deficient mice. Neurosci Lett 446(1):56\u201358. doi: 10.1016\/j.neulet.2008.08.089","journal-title":"Neurosci Lett"},{"issue":"12","key":"9879_CR192","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1007\/s00415-009-0063-7","volume":"255","author":"KJ Bharucha","year":"2008","unstructured":"Bharucha KJ, Friedman JK, Vincent AS, Ross ED (2008) Lower serum ceruloplasmin levels correlate with younger age of onset in Parkinson\u2019s disease. J Neurol 255(12):1957\u20131962. doi: 10.1007\/s00415-009-0063-7","journal-title":"J Neurol"},{"issue":"1","key":"9879_CR193","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1365-2869.2004.00403.x","volume":"14","author":"S Mizuno","year":"2005","unstructured":"Mizuno S, Mihara T, Miyaoka T, Inagaki T, Horiguchi J (2005) CSF iron, ferritin and transferrin levels in restless legs syndrome. J Sleep Res 14(1):43\u201347. doi: 10.1111\/j.1365-2869.2004.00403.x","journal-title":"J Sleep Res"},{"issue":"3","key":"9879_CR194","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1074\/jbc.M804079200","volume":"284","author":"N Tapryal","year":"2009","unstructured":"Tapryal N, Mukhopadhyay C, Das D, Fox PL, Mukhopadhyay CK (2009) Reactive oxygen species regulate ceruloplasmin by a novel mRNA decay mechanism involving its 3\u2019-untranslated region: implications in neurodegenerative diseases. J Biol Chem 284(3):1873\u20131883. doi: 10.1074\/jbc.M804079200","journal-title":"J Biol Chem"},{"issue":"4","key":"9879_CR195","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1002\/ana.23817","volume":"73","author":"S Ayton","year":"2013","unstructured":"Ayton S, Lei P, Duce JA, Wong BX, Sedjahtera A, Adlard PA, Bush AI, Finkelstein DI (2013) Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease. Ann Neurol 73(4):554\u2013559. doi: 10.1002\/ana.23817","journal-title":"Ann Neurol"},{"issue":"12","key":"9879_CR196","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.1002\/pmic.200400848","volume":"4","author":"M Basso","year":"2004","unstructured":"Basso M, Giraudo S, Corpillo D, Bergamasco B, Lopiano L, Fasano M (2004) Proteome analysis of human substantia nigra in Parkinson\u2019s disease. Proteomics 4(12):3943\u20133952. doi: 10.1002\/pmic.200400848","journal-title":"Proteomics"},{"issue":"11","key":"9879_CR197","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1161\/01.RES.84.11.1302","volume":"84","author":"RG Tsushima","year":"1999","unstructured":"Tsushima RG, Wickenden AD, Bouchard RA, Oudit GY, Liu PP, Backx PH (1999) Modulation of iron uptake in heart by L-type Ca2+ channel modifiers: possible implications in iron overload. Circ Res 84(11):1302\u20131309","journal-title":"Circ Res"},{"issue":"9","key":"9879_CR198","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/nm920","volume":"9","author":"GY Oudit","year":"2003","unstructured":"Oudit GY, Sun H, Trivieri MG, Koch SE, Dawood F, Ackerley C, Yazdanpanah M, Wilson GJ, Schwartz A, Liu PP, Backx PH (2003) L-type Ca2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy. Nat Med 9(9):1187\u20131194. doi: 10.1038\/nm920","journal-title":"Nat Med"},{"key":"9879_CR199","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-1-4899-1775-1_2","volume":"4","author":"M Waard De","year":"1996","unstructured":"De Waard M, Gurnett CA, Campbell KP (1996) Structural and functional diversity of voltage-activated calcium channels. Ion Channels 4:41\u201387","journal-title":"Ion Channels"},{"issue":"10","key":"9879_CR200","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1007\/s11064-007-9313-1","volume":"32","author":"JA Gaasch","year":"2007","unstructured":"Gaasch JA, Geldenhuys WJ, Lockman PR, Allen DD, Van der Schyf CJ (2007) Voltage-gated calcium channels provide an alternate route for iron uptake in neuronal cell cultures. Neurochem Res 32(10):1686\u20131693. doi: 10.1007\/s11064-007-9313-1","journal-title":"Neurochem Res"},{"key":"9879_CR201","first-page":"214","volume":"16","author":"B Liss","year":"2001","unstructured":"Liss B, Roeper J (2001) ATP-sensitive potassium channels in dopaminergic neurons: transducers of mitochondrial dysfunction. News Physiol Sci 16:214\u2013217","journal-title":"News Physiol Sci"},{"issue":"12","key":"9879_CR202","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1038\/nn1570","volume":"8","author":"B Liss","year":"2005","unstructured":"Liss B, Haeckel O, Wildmann J, Miki T, Seino S, Roeper J (2005) K-ATP channels promote the differential degeneration of dopaminergic midbrain neurons. Nat Neurosci 8(12):1742\u20131751. doi: 10.1038\/nn1570","journal-title":"Nat Neurosci"},{"issue":"9","key":"9879_CR203","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1038\/nn.3185","volume":"15","author":"J Schiemann","year":"2012","unstructured":"Schiemann J, Schlaudraff F, Klose V, Bingmer M, Seino S, Magill PJ, Zaghloul KA, Schneider G, Liss B, Roeper J (2012) K-ATP channels in dopamine substantia nigra neurons control bursting and novelty-induced exploration. Nat Neurosci 15(9):1272\u20131280. doi: 10.1038\/nn.3185","journal-title":"Nat Neurosci"},{"issue":"2","key":"9879_CR204","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0306-4522(95)00483-1","volume":"71","author":"YX Li","year":"1996","unstructured":"Li YX, Bertram R, Rinzel J (1996) Modeling N-methyl-D-aspartate-induced bursting in dopamine neurons. Neuroscience 71(2):397\u2013410","journal-title":"Neuroscience"},{"issue":"7148","key":"9879_CR205","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1038\/nature05865","volume":"447","author":"CS Chan","year":"2007","unstructured":"Chan CS, Guzman JN, Ilijic E, Mercer JN, Rick C, Tkatch T, Meredith GE, Surmeier DJ (2007) \u2018Rejuvenation\u2019 protects neurons in mouse models of Parkinson\u2019s disease. Nature 447(7148):1081\u20131086. doi: 10.1038\/nature05865","journal-title":"Nature"},{"issue":"7324","key":"9879_CR206","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/nature09536","volume":"468","author":"JN Guzman","year":"2010","unstructured":"Guzman JN, Sanchez-Padilla J, Wokosin D, Kondapalli J, Ilijic E, Schumacker PT, Surmeier DJ (2010) Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1. Nature 468(7324):696\u2013700. doi: 10.1038\/nature09536","journal-title":"Nature"},{"issue":"6641","key":"9879_CR207","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/41343","volume":"388","author":"H Gunshin","year":"1997","unstructured":"Gunshin H, Mackenzie B, Berger UV, Gunshin Y, Romero MF, Boron WF, Nussberger S, Gollan JL, Hediger MA (1997) Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 388(6641):482\u2013488. doi: 10.1038\/41343","journal-title":"Nature"},{"issue":"Suppl","key":"9879_CR208","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1002\/ana.410320703","volume":"32","author":"CW Olanow","year":"1992","unstructured":"Olanow CW (1992) An introduction to the free radical hypothesis in Parkinson\u2019s disease. Ann Neurol 32(Suppl):S2\u2013S9","journal-title":"Ann Neurol"},{"issue":"5","key":"9879_CR209","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0197-4580(02)00186-0","volume":"24","author":"I Cantuti-Castelvetri","year":"2003","unstructured":"Cantuti-Castelvetri I, Shukitt-Hale B, Joseph JA (2003) Dopamine neurotoxicity: age-dependent behavioral and histological effects. Neurobiol Aging 24(5):697\u2013706","journal-title":"Neurobiol Aging"},{"issue":"5","key":"9879_CR210","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.tins.2007.03.009","volume":"30","author":"D Sulzer","year":"2007","unstructured":"Sulzer D (2007) Multiple hit hypotheses for dopamine neuron loss in Parkinson\u2019s disease. Trends Neurosci 30(5):244\u2013250. doi: 10.1016\/j.tins.2007.03.009","journal-title":"Trends Neurosci"},{"issue":"3","key":"9879_CR211","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nrd1330","volume":"3","author":"KJ Barnham","year":"2004","unstructured":"Barnham KJ, Masters CL, Bush AI (2004) Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov 3(3):205\u2013214. doi: 10.1038\/nrd1330","journal-title":"Nat Rev Drug Discov"},{"issue":"12","key":"9879_CR212","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/nrn983","volume":"3","author":"J Lotharius","year":"2002","unstructured":"Lotharius J, Brundin P (2002) Pathogenesis of Parkinson\u2019s disease: dopamine, vesicles and alpha-synuclein. Nat Rev Neurosci 3(12):932\u2013942. doi: 10.1038\/nrn983","journal-title":"Nat Rev Neurosci"},{"issue":"4-5","key":"9879_CR213","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s007020050073","volume":"105","author":"FJ Jimenez-Jimenez","year":"1998","unstructured":"Jimenez-Jimenez FJ, Molina JA, Aguilar MV, Meseguer I, Mateos-Vega CJ, Gonzalez-Munoz MJ, de Bustos F, Martinez-Salio A, Orti-Pareja M, Zurdo M, Martinez-Para MC (1998) Cerebrospinal fluid levels of transition metals in patients with Parkinson\u2019s disease. J Neural Transm 105(4-5):497\u2013505","journal-title":"J Neural Transm"},{"issue":"1","key":"9879_CR214","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0006-8993(96)00313-7","volume":"735","author":"Y He","year":"1996","unstructured":"He Y, Thong PS, Lee T, Leong SK, Shi CY, Wong PT, Yuan SY, Watt F (1996) Increased iron in the substantia nigra of 6-OHDA induced parkinsonian rats: a nuclear microscopy study. Brain Res 735(1):149\u2013153","journal-title":"Brain Res"},{"issue":"3","key":"9879_CR215","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1088\/0031-9155\/54\/3\/012","volume":"54","author":"BF Popescu","year":"2009","unstructured":"Popescu BF, George MJ, Bergmann U, Garachtchenko AV, Kelly ME, McCrea RP, Luning K, Devon RM, George GN, Hanson AD, Harder SM, Chapman LD, Pickering IJ, Nichol H (2009) Mapping metals in Parkinson\u2019s and normal brain using rapid-scanning x-ray fluorescence. Phys Med Biol 54(3):651\u2013663. doi: 10.1088\/0031-9155\/54\/3\/012","journal-title":"Phys Med Biol"},{"issue":"4","key":"9879_CR216","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1111\/j.1471-4159.2005.03638.x","volume":"96","author":"M Fasano","year":"2006","unstructured":"Fasano M, Bergamasco B, Lopiano L (2006) Modifications of the iron-neuromelanin system in Parkinson\u2019s disease. J Neurochem 96(4):909\u2013916. doi: 10.1111\/j.1471-4159.2005.03638.x","journal-title":"J Neurochem"},{"issue":"2","key":"9879_CR217","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1471-4159.2001.00608.x","volume":"79","author":"D Berg","year":"2001","unstructured":"Berg D, Gerlach M, Youdim MB, Double KL, Zecca L, Riederer P, Becker G (2001) Brain iron pathways and their relevance to Parkinson\u2019s disease. J Neurochem 79(2):225\u2013236","journal-title":"J Neurochem"},{"issue":"7 Suppl 2","key":"9879_CR218","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1212\/WNL.67.7_suppl_2.S8","volume":"67","author":"L Zecca","year":"2006","unstructured":"Zecca L, Zucca FA, Albertini A, Rizzio E, Fariello RG (2006) A proposed dual role of neuromelanin in the pathogenesis of Parkinson\u2019s disease. Neurology 67(7 Suppl 2):S8\u2013S11","journal-title":"Neurology"},{"issue":"4","key":"9879_CR219","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1111\/j.1471-4159.2008.05541.x","volume":"106","author":"L Zecca","year":"2008","unstructured":"Zecca L, Casella L, Albertini A, Bellei C, Zucca FA, Engelen M, Zadlo A, Szewczyk G, Zareba M, Sarna T (2008) Neuromelanin can protect against iron-mediated oxidative damage in system modeling iron overload of brain aging and Parkinson\u2019s disease. J Neurochem 106(4):1866\u20131875. doi: 10.1111\/j.1471-4159.2008.05541.x","journal-title":"J Neurochem"},{"issue":"3","key":"9879_CR220","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0014-5793(01)03269-0","volume":"510","author":"L Zecca","year":"2002","unstructured":"Zecca L, Fariello R, Riederer P, Sulzer D, Gatti A, Tampellini D (2002) The absolute concentration of nigral neuromelanin, assayed by a new sensitive method, increases throughout the life and is dramatically decreased in Parkinson\u2019s disease. FEBS Lett 510(3):216\u2013220","journal-title":"FEBS Lett"},{"issue":"3","key":"9879_CR221","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/jnc.12739","volume":"130","author":"M Muller","year":"2014","unstructured":"Muller M, Leavitt BR (2014) Iron dysregulation in Huntington\u2019s disease. J Neurochem 130(3):328\u2013350. doi: 10.1111\/jnc.12739","journal-title":"J Neurochem"},{"key":"9879_CR222","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0079-6123(08)61770-7","volume":"94","author":"LS Forno","year":"1992","unstructured":"Forno LS, DeLanney LE, Irwin I, Di Monte D, Langston JW (1992) Astrocytes and Parkinson\u2019s disease. Prog Brain Res 94:429\u2013436","journal-title":"Prog Brain Res"},{"issue":"2","key":"9879_CR223","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.bbadis.2007.12.002","volume":"1782","author":"S Oshiro","year":"2008","unstructured":"Oshiro S, Kawamura K, Zhang C, Sone T, Morioka MS, Kobayashi S, Nakajima K (2008) Microglia and astroglia prevent oxidative stress-induced neuronal cell death: implications for aceruloplasminemia. Biochim Biophys Acta 1782(2):109\u2013117. doi: 10.1016\/j.bbadis.2007.12.002","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"9879_CR224","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0925-4439(00)00065-X","volume":"1502","author":"S Oshiro","year":"2000","unstructured":"Oshiro S, Kawahara M, Kuroda Y, Zhang C, Cai Y, Kitajima S, Shirao M (2000) Glial cells contribute more to iron and aluminum accumulation but are more resistant to oxidative stress than neuronal cells. Biochim Biophys Acta 1502(3):405\u2013414","journal-title":"Biochim Biophys Acta"},{"issue":"14","key":"9879_CR225","doi-asserted-by":"crossref","first-page":"5848","DOI":"10.1523\/JNEUROSCI.22-14-05848.2002","volume":"22","author":"GJ Kress","year":"2002","unstructured":"Kress GJ, Dineley KE, Reynolds IJ (2002) The relationship between intracellular free iron and cell injury in cultured neurons, astrocytes, and oligodendrocytes. J Neurosci 22(14):5848\u20135855, 20026601","journal-title":"J Neurosci"},{"issue":"5","key":"9879_CR226","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1046\/j.1471-4159.2003.02236.x","volume":"88","author":"HH Hoepken","year":"2004","unstructured":"Hoepken HH, Korten T, Robinson SR, Dringen R (2004) Iron accumulation, iron-mediated toxicity and altered levels of ferritin and transferrin receptor in cultured astrocytes during incubation with ferric ammonium citrate. J Neurochem 88(5):1194\u20131202","journal-title":"J Neurochem"},{"issue":"5","key":"9879_CR227","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.neuropharm.2004.12.003","volume":"48","author":"N Raicevic","year":"2005","unstructured":"Raicevic N, Mladenovic A, Perovic M, Harhaji L, Miljkovic D, Trajkovic V (2005) Iron protects astrocytes from 6-hydroxydopamine toxicity. Neuropharmacology 48(5):720\u2013731. doi: 10.1016\/j.neuropharm.2004.12.003","journal-title":"Neuropharmacology"},{"issue":"1","key":"9879_CR228","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1023\/A:1020718718550","volume":"16","author":"JR Burdo","year":"2003","unstructured":"Burdo JR, Connor JR (2003) Brain iron uptake and homeostatic mechanisms: an overview. Biometals 16(1):63\u201375","journal-title":"Biometals"},{"issue":"2","key":"9879_CR229","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1367-5931(99)00073-3","volume":"4","author":"AI Bush","year":"2000","unstructured":"Bush AI (2000) Metals and neuroscience. Curr Opin Chem Biol 4(2):184\u2013191","journal-title":"Curr Opin Chem Biol"},{"issue":"9","key":"9879_CR230","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1002\/mds.21020","volume":"21","author":"D Berg","year":"2006","unstructured":"Berg D, Hochstrasser H (2006) Iron metabolism in Parkinsonian syndromes. Mov Disord 21(9):1299\u20131310. doi: 10.1002\/mds.21020","journal-title":"Mov Disord"},{"issue":"5","key":"9879_CR231","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0891-5849(92)90091-T","volume":"12","author":"DW Reif","year":"1992","unstructured":"Reif DW (1992) Ferritin as a source of iron for oxidative damage. Free Radic Biol Med 12(5):417\u2013427","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"9879_CR232","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/74994","volume":"6","author":"G Kroemer","year":"2000","unstructured":"Kroemer G, Reed JC (2000) Mitochondrial control of cell death. Nat Med 6(5):513\u2013519. doi: 10.1038\/74994","journal-title":"Nat Med"},{"issue":"2","key":"9879_CR233","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.brainresrev.2007.04.007","volume":"57","author":"JW Simpkins","year":"2008","unstructured":"Simpkins JW, Dykens JA (2008) Mitochondrial mechanisms of estrogen neuroprotection. Brain Res Rev 57(2):421\u2013430. doi: 10.1016\/j.brainresrev.2007.04.007","journal-title":"Brain Res Rev"},{"issue":"52","key":"9879_CR234","doi-asserted-by":"publisher","first-page":"42655","DOI":"10.1074\/jbc.M505910200","volume":"280","author":"R Ved","year":"2005","unstructured":"Ved R, Saha S, Westlund B, Perier C, Burnam L, Sluder A, Hoener M, Rodrigues CM, Alfonso A, Steer C, Liu L, Przedborski S, Wolozin B (2005) Similar patterns of mitochondrial vulnerability and rescue induced by genetic modification of alpha-synuclein, parkin, and DJ-1 in Caenorhabditis elegans. J Biol Chem 280(52):42655\u201342668. doi: 10.1074\/jbc.M505910200","journal-title":"J Biol Chem"},{"issue":"6","key":"9879_CR235","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1111\/j.1471-4159.2008.05743.x","volume":"107","author":"Y Ikeda","year":"2008","unstructured":"Ikeda Y, Tsuji S, Satoh A, Ishikura M, Shirasawa T, Shimizu T (2008) Protective effects of astaxanthin on 6-hydroxydopamine-induced apoptosis in human neuroblastoma SH-SY5Y cells. J Neurochem 107(6):1730\u20131740. doi: 10.1111\/j.1471-4159.2008.05743.x","journal-title":"J Neurochem"},{"issue":"47","key":"9879_CR236","doi-asserted-by":"publisher","first-page":"34479","DOI":"10.1074\/jbc.M705426200","volume":"282","author":"Z Weng","year":"2007","unstructured":"Weng Z, Signore AP, Gao Y, Wang S, Zhang F, Hastings T, Yin XM, Chen J (2007) Leptin protects against 6-hydroxydopamine-induced dopaminergic cell death via mitogen-activated protein kinase signaling. J Biol Chem 282(47):34479\u201334491. doi: 10.1074\/jbc.M705426200","journal-title":"J Biol Chem"},{"issue":"6","key":"9879_CR237","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1046\/j.1471-4159.1998.70062492.x","volume":"70","author":"KL Double","year":"1998","unstructured":"Double KL, Maywald M, Schmittel M, Riederer P, Gerlach M (1998) In vitro studies of ferritin iron release and neurotoxicity. J Neurochem 70(6):2492\u20132499","journal-title":"J Neurochem"},{"issue":"2","key":"9879_CR238","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.bbrc.2005.05.150","volume":"333","author":"X Zhang","year":"2005","unstructured":"Zhang X, Xie W, Qu S, Pan T, Wang X, Le W (2005) Neuroprotection by iron chelator against proteasome inhibitor-induced nigral degeneration. Biochem Biophys Res Commun 333(2):544\u2013549. doi: 10.1016\/j.bbrc.2005.05.150","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"9879_CR239","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1046\/j.1471-4159.2002.00821.x","volume":"81","author":"KS McNaught","year":"2002","unstructured":"McNaught KS, Mytilineou C, Jnobaptiste R, Yabut J, Shashidharan P, Jennert P, Olanow CW (2002) Impairment of the ubiquitin-proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures. J Neurochem 81(2):301\u2013306","journal-title":"J Neurochem"},{"issue":"2","key":"9879_CR240","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.nbd.2009.09.024","volume":"37","author":"W Zhu","year":"2010","unstructured":"Zhu W, Li X, Xie W, Luo F, Kaur D, Andersen JK, Jankovic J, Le W (2010) Genetic iron chelation protects against proteasome inhibition-induced dopamine neuron degeneration. Neurobiol Dis 37(2):307\u2013313. doi: 10.1016\/j.nbd.2009.09.024","journal-title":"Neurobiol Dis"},{"issue":"7","key":"9879_CR241","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1128\/MCB.01111-06","volume":"27","author":"J Wang","year":"2007","unstructured":"Wang J, Fillebeen C, Chen G, Biederbick A, Lill R, Pantopoulos K (2007) Iron-dependent degradation of apo-IRP1 by the ubiquitin-proteasome pathway. Mol Cell Biol 27(7):2423\u20132430. doi: 10.1128\/MCB.01111-06","journal-title":"Mol Cell Biol"},{"issue":"2","key":"9879_CR242","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.neurobiolaging.2014.10.021","volume":"36","author":"W Jia","year":"2015","unstructured":"Jia W, Xu H, Du X, Jiang H, Xie J (2015) Ndfip1 attenuated 6-OHDA-induced iron accumulation via regulating the degradation of DMT1. Neurobiol Aging 36(2):1183\u20131193. doi: 10.1016\/j.neurobiolaging.2014.10.021","journal-title":"Neurobiol Aging"},{"issue":"28","key":"9879_CR243","doi-asserted-by":"crossref","first-page":"19509","DOI":"10.1074\/jbc.274.28.19509","volume":"274","author":"SJ Wood","year":"1999","unstructured":"Wood SJ, Wypych J, Steavenson S, Louis JC, Citron M, Biere AL (1999) alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson\u2019s disease. J Biol Chem 274(28):19509\u201319512","journal-title":"J Biol Chem"},{"issue":"2","key":"9879_CR244","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/ng0298-106","volume":"18","author":"R Kruger","year":"1998","unstructured":"Kruger R, Kuhn W, Muller T, Woitalla D, Graeber M, Kosel S, Przuntek H, Epplen JT, Schols L, Riess O (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson\u2019s disease. Nat Genet 18(2):106\u2013108. doi: 10.1038\/ng0298-106","journal-title":"Nat Genet"},{"issue":"5321","key":"9879_CR245","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaum RL (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease. Science 276(5321):2045\u20132047","journal-title":"Science"},{"issue":"2","key":"9879_CR246","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1471-4159.1991.tb08170.x","volume":"56","author":"EC Hirsch","year":"1991","unstructured":"Hirsch EC, Brandel JP, Galle P, Javoy-Agid F, Agid Y (1991) Iron and aluminum increase in the substantia nigra of patients with Parkinson\u2019s disease: an X-ray microanalysis. J Neurochem 56(2):446\u2013451","journal-title":"J Neurochem"},{"issue":"16","key":"9879_CR247","doi-asserted-by":"publisher","first-page":"10992","DOI":"10.1074\/jbc.M709634200","volume":"283","author":"M Kostka","year":"2008","unstructured":"Kostka M, Hogen T, Danzer KM, Levin J, Habeck M, Wirth A, Wagner R, Glabe CG, Finger S, Heinzelmann U, Garidel P, Duan W, Ross CA, Kretzschmar H, Giese A (2008) Single particle characterization of iron-induced pore-forming alpha-synuclein oligomers. J Biol Chem 283(16):10992\u201311003. doi: 10.1074\/jbc.M709634200","journal-title":"J Biol Chem"},{"issue":"1","key":"9879_CR248","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1471-4159.2007.04764.x","volume":"103","author":"VN Uversky","year":"2007","unstructured":"Uversky VN (2007) Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation. J Neurochem 103(1):17\u201337. doi: 10.1111\/j.1471-4159.2007.04764.x","journal-title":"J Neurochem"},{"issue":"10","key":"9879_CR249","doi-asserted-by":"publisher","first-page":"9678","DOI":"10.1074\/jbc.M409946200","volume":"280","author":"NB Cole","year":"2005","unstructured":"Cole NB, Murphy DD, Lebowitz J, Di Noto L, Levine RL, Nussbaum RL (2005) Metal-catalyzed oxidation of alpha-synuclein: helping to define the relationship between oligomers, protofibrils, and filaments. J Biol Chem 280(10):9678\u20139690. doi: 10.1074\/jbc.M409946200","journal-title":"J Biol Chem"},{"issue":"18","key":"9879_CR250","doi-asserted-by":"publisher","first-page":"16116","DOI":"10.1074\/jbc.M107866200","volume":"277","author":"N Golts","year":"2002","unstructured":"Golts N, Snyder H, Frasier M, Theisler C, Choi P, Wolozin B (2002) Magnesium inhibits spontaneous and iron-induced aggregation of alpha-synuclein. J Biol Chem 277(18):16116\u201316123. doi: 10.1074\/jbc.M107866200","journal-title":"J Biol Chem"},{"issue":"1","key":"9879_CR251","doi-asserted-by":"publisher","first-page":"e15814","DOI":"10.1371\/journal.pone.0015814","volume":"6","author":"P Davies","year":"2011","unstructured":"Davies P, Moualla D, Brown DR (2011) Alpha-synuclein is a cellular ferrireductase. PLoS One 6(1):e15814. doi: 10.1371\/journal.pone.0015814","journal-title":"PLoS One"},{"issue":"6","key":"9879_CR252","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1042\/BST20130130","volume":"41","author":"DR Brown","year":"2013","unstructured":"Brown DR (2013) alpha-Synuclein as a ferrireductase. Biochem Soc Trans 41(6):1513\u20131517. doi: 10.1042\/BST20130130","journal-title":"Biochem Soc Trans"},{"key":"9879_CR253","doi-asserted-by":"publisher","unstructured":"Ortega R, Carmona A, Roudeau S, Perrin L, Ducic T, Carboni E, Bohic S, Cloetens P, Lingor P (2015) alpha-Synuclein Over-Expression Induces Increased Iron Accumulation and Redistribution in Iron-Exposed Neurons. Mol Neurobiol. doi: 10.1007\/s12035-015-9146-x","DOI":"10.1007\/s12035-015-9146-x"},{"issue":"3","key":"9879_CR254","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/sj.mp.4001937","volume":"12","author":"AL Friedlich","year":"2007","unstructured":"Friedlich AL, Tanzi RE, Rogers JT (2007) The 5\u2019-untranslated region of Parkinson\u2019s disease alpha-synuclein messengerRNA contains a predicted iron responsive element. Mol Psychiatry 12(3):222\u2013223. doi: 10.1038\/sj.mp.4001937","journal-title":"Mol Psychiatry"},{"issue":"3","key":"9879_CR255","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.3390\/ijms10031226","volume":"10","author":"D Olivares","year":"2009","unstructured":"Olivares D, Huang X, Branden L, Greig NH, Rogers JT (2009) Physiological and Pathological Role of Alpha-synuclein in Parkinson\u2019s Disease Through Iron Mediated Oxidative Stress; The Role of a Putative Iron-responsive Element. Int J Mol Sci 10(3):1226\u20131260. doi: 10.3390\/ijms10031226","journal-title":"Int J Mol Sci"},{"issue":"4","key":"9879_CR256","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.bbadis.2016.01.002","volume":"1862","author":"ZJ Zhu","year":"2016","unstructured":"Zhu ZJ, Wu KC, Yung WH, Qian ZM, Ke Y (2016) Differential interaction between iron and mutant alpha-synuclein causes distinctive Parkinsonian phenotypes in Drosophila. Biochim Biophys Acta 1862(4):518\u2013525. doi: 10.1016\/j.bbadis.2016.01.002","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"9879_CR257","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/ng571","volume":"28","author":"AR Curtis","year":"2001","unstructured":"Curtis AR, Fey C, Morris CM, Bindoff LA, Ince PG, Chinnery PF, Coulthard A, Jackson MJ, Jackson AP, McHale DP, Hay D, Barker WA, Markham AF, Bates D, Curtis A, Burn J (2001) Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat Genet 28(4):350\u2013354. doi: 10.1038\/ng571","journal-title":"Nat Genet"},{"issue":"7","key":"9879_CR258","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1073\/pnas.92.7.2539","volume":"92","author":"ZL Harris","year":"1995","unstructured":"Harris ZL, Takahashi Y, Miyajima H, Serizawa M, MacGillivray RT, Gitlin JD (1995) Aceruloplasminemia: molecular characterization of this disorder of iron metabolism. Proc Natl Acad Sci U S A 92(7):2539\u20132543","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7083","key":"9879_CR259","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/nature04711","volume":"440","author":"CG Nichols","year":"2006","unstructured":"Nichols CG (2006) KATP channels as molecular sensors of cellular metabolism. Nature 440(7083):470\u2013476. doi: 10.1038\/nature04711","journal-title":"Nature"},{"issue":"1-2","key":"9879_CR260","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0006-8993(03)03222-0","volume":"986","author":"A Thomzig","year":"2003","unstructured":"Thomzig A, Pruss H, Veh RW (2003) The Kir6.1-protein, a pore-forming subunit of ATP-sensitive potassium channels, is prominently expressed by giant cholinergic interneurons in the striatum of the rat brain. Brain Res 986(1-2):132\u2013138","journal-title":"Brain Res"},{"issue":"1-2","key":"9879_CR261","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0006-8993(94)90938-5","volume":"642","author":"S Holemans","year":"1994","unstructured":"Holemans S, Javoy-Agid F, Agid Y, De Paermentier F, Laterre EC, Maloteaux JM (1994) Sulfonylurea binding sites in normal human brain and in Parkinson\u2019s disease, progressive supranuclear palsy and Huntington\u2019s disease. Brain Res 642(1-2):327\u2013333","journal-title":"Brain Res"},{"issue":"4","key":"9879_CR262","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S1353-8020(00)00050-X","volume":"7","author":"M Takanashi","year":"2001","unstructured":"Takanashi M, Mochizuki H, Yokomizo K, Hattori N, Mori H, Yamamura Y, Mizuno Y (2001) Iron accumulation in the substantia nigra of autosomal recessive juvenile parkinsonism (ARJP). Parkinsonism Relat Disord 7(4):311\u2013314","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"9879_CR263","doi-asserted-by":"publisher","first-page":"879","DOI":"10.3233\/JAD-2009-1010","volume":"16","author":"S Altamura","year":"2009","unstructured":"Altamura S, Muckenthaler MU (2009) Iron toxicity in diseases of aging: Alzheimer\u2019s disease, Parkinson\u2019s disease and atherosclerosis. J Alzheimers Dis 16(4):879\u2013895. doi: 10.3233\/JAD-2009-1010","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"9879_CR264","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.neuroimage.2011.08.019","volume":"59","author":"V Antharam","year":"2012","unstructured":"Antharam V, Collingwood JF, Bullivant JP, Davidson MR, Chandra S, Mikhaylova A, Finnegan ME, Batich C, Forder JR, Dobson J (2012) High field magnetic resonance microscopy of the human hippocampus in Alzheimer\u2019s disease: quantitative imaging and correlation with iron. Neuroimage 59(2):1249\u20131260. doi: 10.1016\/j.neuroimage.2011.08.019","journal-title":"Neuroimage"},{"issue":"2","key":"9879_CR265","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.expneurol.2004.08.014","volume":"190","author":"CW Levenson","year":"2004","unstructured":"Levenson CW, Cutler RG, Ladenheim B, Cadet JL, Hare J, Mattson MP (2004) Role of dietary iron restriction in a mouse model of Parkinson\u2019s disease. Exp Neurol 190(2):506\u2013514. doi: 10.1016\/j.expneurol.2004.08.014","journal-title":"Exp Neurol"},{"key":"9879_CR266","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1196\/annals.1306.008","volume":"1012","author":"S Shoham","year":"2004","unstructured":"Shoham S, Youdim MB (2004) Nutritional iron deprivation attenuates kainate-induced neurotoxicity in rats: implications for involvement of iron in neurodegeneration. Ann N Y Acad Sci 1012:94\u2013114","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"9879_CR267","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00702-010-0531-3","volume":"118","author":"DT Dexter","year":"2011","unstructured":"Dexter DT, Statton SA, Whitmore C, Freinbichler W, Weinberger P, Tipton KF, Della Corte L, Ward RJ, Crichton RR (2011) Clinically available iron chelators induce neuroprotection in the 6-OHDA model of Parkinson\u2019s disease after peripheral administration. J Neural Transm 118(2):223\u2013231. doi: 10.1007\/s00702-010-0531-3","journal-title":"J Neural Transm"},{"issue":"3","key":"9879_CR268","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/j.neurobiolaging.2014.10.026","volume":"36","author":"O Bar-Am","year":"2015","unstructured":"Bar-Am O, Amit T, Kupershmidt L, Aluf Y, Mechlovich D, Kabha H, Danovitch L, Zurawski VR, Youdim MB, Weinreb O (2015) Neuroprotective and neurorestorative activities of a novel iron chelator-brain selective monoamine oxidase-A\/monoamine oxidase-B inhibitor in animal models of Parkinson\u2019s disease and aging. Neurobiol Aging 36(3):1529\u20131542. doi: 10.1016\/j.neurobiolaging.2014.10.026","journal-title":"Neurobiol Aging"},{"issue":"4","key":"9879_CR269","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1111\/j.1471-4159.2006.04265.x","volume":"100","author":"L Kalfon","year":"2007","unstructured":"Kalfon L, Youdim MB, Mandel SA (2007) Green tea polyphenol (-) -epigallocatechin-3-gallate promotes the rapid protein kinase C- and proteasome-mediated degradation of Bad: implications for neuroprotection. J Neurochem 100(4):992\u20131002. doi: 10.1111\/j.1471-4159.2006.04265.x","journal-title":"J Neurochem"},{"issue":"2","key":"9879_CR270","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.bcp.2009.03.031","volume":"78","author":"J Wang","year":"2009","unstructured":"Wang J, Du XX, Jiang H, Xie JX (2009) Curcumin attenuates 6-hydroxydopamine-induced cytotoxicity by anti-oxidation and nuclear factor-kappa B modulation in MES23.5 cells. Biochem Pharmacol 78(2):178\u2013183. doi: 10.1016\/j.bcp.2009.03.031","journal-title":"Biochem Pharmacol"},{"key":"9879_CR271","doi-asserted-by":"publisher","unstructured":"Wang YQ, Wang MY, Fu XR, Peng Y, Gao GF, Fan YM, Duan XL, Zhao BL, Chang YZ, Shi ZH (2015) Neuroprotective effects of ginkgetin against neuroinjury in Parkinson\u2019s disease model induced by MPTP via chelating iron. Free Radic Res:1-12. doi: 10.3109\/10715762.2015.1032958","DOI":"10.3109\/10715762.2015.1032958"},{"issue":"1-2","key":"9879_CR272","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0166-4328(02)00092-X","volume":"134","author":"JL Beard","year":"2002","unstructured":"Beard JL, Erikson KM, Jones BC (2002) Neurobehavioral analysis of developmental iron deficiency in rats. Behav Brain Res 134(1-2):517\u2013524","journal-title":"Behav Brain Res"},{"issue":"11","key":"9879_CR273","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1093\/jn\/130.11.2831","volume":"130","author":"KM Erikson","year":"2000","unstructured":"Erikson KM, Jones BC, Beard JL (2000) Iron deficiency alters dopamine transporter functioning in rat striatum. J Nutr 130(11):2831\u20132837","journal-title":"J Nutr"},{"issue":"1","key":"9879_CR274","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF03033574","volume":"14","author":"MB Youdim","year":"2008","unstructured":"Youdim MB (2008) Brain iron deficiency and excess; cognitive impairment and neurodegeneration with involvement of striatum and hippocampus. Neurotox Res 14(1):45\u201356","journal-title":"Neurotox Res"},{"issue":"4","key":"9879_CR275","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/jn\/133.4.1174","volume":"133","author":"J Beard","year":"2003","unstructured":"Beard J, Erikson KM, Jones BC (2003) Neonatal iron deficiency results in irreversible changes in dopamine function in rats. J Nutr 133(4):1174\u20131179","journal-title":"J Nutr"},{"issue":"1","key":"9879_CR276","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/jn\/137.1.118","volume":"137","author":"EL Unger","year":"2007","unstructured":"Unger EL, Paul T, Murray-Kolb LE, Felt B, Jones BC, Beard JL (2007) Early iron deficiency alters sensorimotor development and brain monoamines in rats. J Nutr 137(1):118\u2013124","journal-title":"J Nutr"},{"issue":"7","key":"9879_CR277","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/S1474-4422(04)00809-9","volume":"3","author":"PM Doraiswamy","year":"2004","unstructured":"Doraiswamy PM, Finefrock AE (2004) Metals in our minds: therapeutic implications for neurodegenerative disorders. Lancet Neurol 3(7):431\u2013434. doi: 10.1016\/S1474-4422(04)00809-9","journal-title":"Lancet Neurol"},{"issue":"2","key":"9879_CR278","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.freeradbiomed.2009.11.004","volume":"48","author":"N Song","year":"2010","unstructured":"Song N, Wang J, Jiang H, Xie J (2010) Ferroportin 1 but not hephaestin contributes to iron accumulation in a cell model of Parkinson\u2019s disease. Free Radic Biol Med 48(2):332\u2013341. doi: 10.1016\/j.freeradbiomed.2009.11.004","journal-title":"Free Radic Biol Med"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-016-9879-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-016-9879-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-016-9879-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-016-9879-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T23:03:25Z","timestamp":1655420605000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-016-9879-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,2]]},"references-count":278,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["9879"],"URL":"https:\/\/doi.org\/10.1007\/s12035-016-9879-1","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,2]]}}}